{
  "meta": {
    "title": "00366_Late_Night_Pyq_Inicet_Obg-3",
    "url": "https://brainandscalpel.vercel.app/00366-late-night-pyq-inicet-obg-3-a2c28d4d.html",
    "scrapedAt": "2025-11-29T18:10:41.572Z"
  },
  "questions": [
    {
      "id": 54775,
      "choices": [
        {
          "id": 218565,
          "text": "<p><span style=\"font-size:12.0pt;\">Mid cavity forceps</span></p>"
        },
        {
          "id": 218566,
          "text": "<p><span style=\"font-size:12.0pt;\">Low forceps</span></p>"
        },
        {
          "id": 218567,
          "text": "<p><span style=\"font-size:12.0pt;\">Outlet forceps</span></p>"
        },
        {
          "id": 218568,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventouse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida is in the 2nd stage of labor for 2 hours. The head is at +3 with caput present and the fetal heart rate (FHR) is dropping to 90 bpm. What is the best way to deliver the head? (INICET MAY 2024)</span></p>",
      "unique_key": "Q8986970",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769998,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Outlet forceps</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this scenario, the patient is a primigravida (a woman pregnant for the first time) who is in the second stage of labor, which has been ongoing for 2 hours. The second stage of labor in a primigravida can be allowed up to 3 hours if the mother and fetus are stable. However, in this case, the fetal heart rate has dropped to 90 bpm, indicating fetal distress, and the head is at +3 station, meaning it is very low in the pelvis, almost at the pelvic floor.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Outlet forceps</strong> are specifically designed for situations where the fetal head is at +3 station or lower. The head is visible at the introitus without separating the labia, and delivery needs to be expedited due to fetal distress. In this case, the application of outlet forceps is preferred because it allows for a quicker delivery compared to other methods. This is critical when there is evidence of fetal distress, as time is of the essence to reduce the risk of hypoxia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mid cavity forceps</strong> are used when the fetal head is higher in the pelvis, typically at 0 to +1 station. This option is not suitable in this case because the head is much lower, at +3 station.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low forceps</strong> are used when the head is at +2 station, slightly higher than in this scenario. They are not appropriate when the head is at +3 station.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ventouse (vacuum extraction)</strong> can be used at various stations, but it is generally slower to apply compared to forceps. Additionally, the presence of caput (swelling of the fetal scalp) can make it difficult to achieve the necessary suction for effective vacuum delivery. Therefore, outlet forceps are preferred in this scenario to ensure a quicker and more effective delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mid cavity forceps:</strong> Incorrect because they are used when the head is at a higher station, typically 0 to +1, and the head is not yet at the pelvic floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Low forceps:</strong> Incorrect because they are more suitable when the head is at +2 station, not when it is already at +3 station.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ventouse (vacuum extraction):</strong> While it could technically be used, it is not the best choice here because of the fetal distress and the presence of caput, which may hinder the effective application of the vacuum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of fetal distress with the fetal head at +3 station, outlet forceps are the preferred method of assisted delivery due to their speed and effectiveness, particularly when caput is present.</span></p>",
      "correct_choice_id": 218567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54785,
      "choices": [
        {
          "id": 218605,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichomoniasis</span></span></p>"
        },
        {
          "id": 218606,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neisseria</span></span></p>"
        },
        {
          "id": 218607,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydia</span></span></p>"
        },
        {
          "id": 218608,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacterial vaginosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman presents with dysuria and yellowish discharge. Gram staining shows gram-negative diplococci. What is the diagnosis? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q9049722",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770007,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Neisseria</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of gram-negative diplococci on a gram stain is a classic finding in infections caused by <strong>Neisseria gonorrhoeae</strong>, which is a sexually transmitted bacterium responsible for gonorrhea. Neisseria gonorrhoeae typically presents with symptoms such as dysuria (painful urination) and a yellowish or purulent discharge, which aligns with the clinical presentation described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gram staining is a key diagnostic tool that helps differentiate bacterial species based on the characteristics of their cell walls. Neisseria gonorrhoeae is a gram-negative diplococcus, meaning it appears as paired spherical bacteria that do not retain the crystal violet stain used in gram staining but do take up the counterstain, appearing pink or red under a microscope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Trichomoniasis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a sexually transmitted infection caused by the protozoan <strong>Trichomonas vaginalis</strong>, which is a flagellated organism. While trichomoniasis can cause dysuria and yellowish discharge, it would not present with gram-negative diplococci on a gram stain. If the organism had flagella, Trichomoniasis would be a consideration, but the gram stain findings rule it out.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Chlamydia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Chlamydia trachomatis is another sexually transmitted bacterium that can cause symptoms similar to those of gonorrhea. However, it does not appear as gram-negative diplococci on gram stain. Instead, it is typically detected by nucleic acid amplification tests (NAAT).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bacterial vaginosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition is characterized by an imbalance in the vaginal flora and typically diagnosed using Amsel&#39;s criteria or by identifying clue cells on microscopy. It is not associated with gram-negative diplococci.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The identification of gram-negative diplococci in a patient with dysuria and yellowish discharge is highly indicative of Neisseria gonorrhoeae infection, a common cause of gonorrhea</span></span></span></p>",
      "correct_choice_id": 218606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5998,
      "choices": [
        {
          "id": 23962,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 cm</span></span></span></p>"
        },
        {
          "id": 23963,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 cm</span></span></span></p>"
        },
        {
          "id": 23964,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7 cm</span></span></span></p>"
        },
        {
          "id": 23965,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10 cm</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the normal uterocervical length?&nbsp;</span></span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5940145",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770028,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 7 cm</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal length of the uterine cavity, including the cervical canal, is usually 6-7 cm. This measurement is essential in gynecological evaluations and procedures.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement helps in assessing normal uterine anatomy and can be used in various clinical procedures such as the insertion of intrauterine devices (IUDs).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovary:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The ovary measures about 3 cm x 2 cm x 1 cm.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fallopian Tube:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The length of the Fallopian tube is about 10 cm, and the lumen is 1-2 mm at the isthmus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal length of the uterine cavity, including the cervical canal, is 6-7 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition Pg 25, Dutta&#39;s textbook of gynecology 6<sup>th</sup> edition Pg 7</span></strong></span></span></p>",
      "correct_choice_id": 23964,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23230,
      "choices": [
        {
          "id": 92884,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 92885,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 92886,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 92887,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Among the given statements, which one would lead you to consider primary amenorrhea as a possibility?&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Failure to attain menarche by 15 years of age</span></li><li><span style=\"font-size:12pt;\">Failure to attain menarche even after 3 years of thelarche</span></li><li><span style=\"font-size:12pt;\">High levels of TSH and short stature</span></li><li><span style=\"font-size:12pt;\">Failure of development of breasts by 13 years of age</span></li></ol>",
      "unique_key": "Q6302277",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary amenorrhea is defined as the absence of menstruation in a girl who has not attained menarche by a certain age or who lacks secondary sexual characteristics. Specifically:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Failure to attain menarche by 15 years of age</strong>: This is a classic indicator of primary amenorrhea, particularly if secondary sexual characteristics have developed. It is an age by which menstruation should have started if there are signs of puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Failure to attain menarche even after 3 years of thelarche</strong>: Thelarche, or breast development, typically occurs around ages 9 to 13. If menarche has not occurred within 3 years after thelarche, it is a reason to investigate primary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Failure of development of breasts by 13 years of age</strong>: The absence of breast development by age 13 indicates a delay in puberty and warrants evaluation for primary amenorrhea if menstruation has not begun by this age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. High levels of TSH and short stature</strong>: While high TSH and short stature may indicate thyroid dysfunction or other endocrine issues, they are not direct indicators of primary amenorrhea. These findings might contribute to secondary causes of amenorrhea or other growth disorders but are not themselves diagnostic criteria for primary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary amenorrhea should be considered if there is failure to attain menarche by 15 years of age, failure to attain menarche even after 3 years of thelarche, or failure of breast development by 13 years of age.</span></p>",
      "correct_choice_id": 92886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23222,
      "choices": [
        {
          "id": 92852,
          "text": "<p><span style=\"font-size:12pt;\">At eight weeks the embryo is bipotent</span></p>"
        },
        {
          "id": 92853,
          "text": "<p><span style=\"font-size:12pt;\">Wolffian duct develops into epididymis and vas deferens on either side of the body</span></p>"
        },
        {
          "id": 92854,
          "text": "<p><span style=\"font-size:12pt;\">Mullerian inhibiting substance inhibits mullerian duct</span></p>"
        },
        {
          "id": 92855,
          "text": "<p><span style=\"font-size:12pt;\">Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is&nbsp;not true&nbsp;about male sexual development? (INICET MAY 2023)</span></p>",
      "unique_key": "Q4868898",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769961,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) At eight weeks the embryo is bipotent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent. The term \"bipotent\" refers to the embryo's capability to develop into either male or female structures, which is true up until about the sixth week of development. By the eighth week, sexual differentiation is already underway, with the influence of the SRY gene causing the gonads to differentiate into testes in 46XY embryos. This differentiation results in a shift away from bipotency, making the embryo committed to developing male characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Wolffian duct develops into epididymis and vas deferens on either side of the body</strong>: This statement is true. The Wolffian ducts, under the influence of testosterone, develop into the male reproductive structures including the epididymis and vas deferens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mullerian inhibiting substance inhibits Mullerian duct</strong>: This statement is true. Mullerian inhibiting substance (MIS), also known as anti-Mullerian hormone (AMH), is produced by Sertoli cells in the testes and inhibits the development of the Mullerian ducts, which would otherwise develop into female reproductive structures such as the uterine tubes and uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</strong>: This statement is true. Dihydrotestosterone (DHT), a potent metabolite of testosterone, is crucial for the development of male external genitalia and secondary sexual characteristics such as facial hair and a deeper voice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent; sexual differentiation has already commenced.</span></p>",
      "correct_choice_id": 92852,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23231,
      "choices": [
        {
          "id": 92888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pain begins after few hours of onset of periods and can last up to 48 hours </span></span></span></p>"
        },
        {
          "id": 92889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is dependent on psychological factors </span></span></span></p>"
        },
        {
          "id": 92890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pain begins 3 days prior to the onset of periods and is present up to the second day of the period </span></span></span></p>"
        },
        {
          "id": 92891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GnRH antagonists are the first line of treatment</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these statements regarding primary dysmenorrhea is true?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q6455908",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769990,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) It Is dependent on psychological factors </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary dysmenorrhea can be dependent on psychological factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary dysmenorrhea</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is associated with the presence of pelvic pathologies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pain begins after few hours of onset of periods and can last up to 48 hours</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pain begins 3 days prior to the onset of periods and is present up to the second day of the period</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pain begins before or with onset of menstrual periods. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GnRH antagonists are the first line of treatment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NSAIDs are the first line of treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary dysmenorrhea, characterized by menstrual pain without underlying pelvic pathology, can be influenced by psychological factors. This type of dysmenorrhea begins before or with the onset of menstrual periods and is typically treated first with NSAIDs, not GnRH antagonists.</span></span></span></p>",
      "correct_choice_id": 92889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5988,
      "choices": [
        {
          "id": 23922,
          "text": "<p><span style=\"font-size:12pt;\">Turner's mosaic</span></p>"
        },
        {
          "id": 23923,
          "text": "<p><span style=\"font-size:12pt;\">Kallman syndrome</span></p>"
        },
        {
          "id": 23924,
          "text": "<p><span style=\"font-size:12pt;\">Sheehan's syndrome</span></p>"
        },
        {
          "id": 23925,
          "text": "<p><span style=\"font-size:12pt;\">Asherman's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cause of secondary amenorrhea?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q8020025",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Kallman syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Kallman syndrome is a condition of hypothalamic hypogonadism that presents as primary amenorrhea with anosmia. It does not cause secondary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Causes of secondary amenorrhea:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Sheehan's syndrome:</strong> This is a condition where the pituitary gland is damaged due to severe blood loss during or after childbirth, leading to secondary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Asherman's syndrome:</strong> This condition involves the formation of scar tissue in the uterine cavity, often as a result of surgical procedures like dilation and curettage (D&amp;C), leading to secondary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Turner mosaic:</strong> This refers to a form of Turner syndrome where some of the cells have the typical 45,X karyotype and others have a different karyotype (e.g., 46,XX). It can lead to secondary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Premature ovarian failure:</strong> This condition occurs when the ovaries stop functioning normally before age 40, causing secondary amenorrhea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Turner's mosaic:</strong> A cause of secondary amenorrhea due to ovarian insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sheehan's syndrome:</strong> A cause of secondary amenorrhea due to pituitary damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Asherman's syndrome:</strong> A cause of secondary amenorrhea due to uterine scarring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Kallman syndrome is a cause of primary amenorrhea due to hypothalamic hypogonadism and anosmia. Secondary amenorrhea can be caused by conditions such as Sheehan's syndrome, Asherman's syndrome, Turner mosaic, and premature ovarian failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition Pg375</strong></span></p>",
      "correct_choice_id": 23923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5993,
      "choices": [
        {
          "id": 23942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-B, 3-D, 4-C</span></span></span></p>"
        },
        {
          "id": 23943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-B, 2-C, 3-D, 4-A</span></span></span></p>"
        },
        {
          "id": 23944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-A, 2-B, 3-C, 4-D</span></span></span></p>"
        },
        {
          "id": 23945,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-D, 2-A, 3-C, 4-B</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following syndromes with their respective karyotypes?&nbsp;</span></span></span>&nbsp;(INICET NOV 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/screenshot-2024-10-14-185037.jpg\" style=\"height:229px; width:700px\" /></p>",
      "unique_key": "Q9307737",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770023,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-A, 2-B, 3-D, 4-C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH syndrome (Mayer-Rokitansky-K&uuml;ster-Hauser):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This syndrome has a karyotype of <strong>46XX</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Swyer Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by <strong>46XY</strong> karyotype.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is due to monosomy X, having a karyotype of <strong>45XO</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen Insensitivity Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition occurs in individuals with a karyotype of <strong>46XY</strong>, where there is a complete androgen insensitivity, resulting in a phenotypically female appearance despite having male (XY) chromosomes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Matching:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 46XX</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Swyer Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 46XY</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 45XO</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen Insensitivity Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 46XY</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the karyotypes associated with different syndromes helps in diagnosing and managing these conditions effectively. MRKH is associated with 46XX, Swyer syndrome with 46XY, Turner syndrome with 45XO, and Androgen Insensitivity Syndrome with 46XY.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg 446,447</span></strong></span></span></p>",
      "correct_choice_id": 23942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54786,
      "choices": [
        {
          "id": 218609,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper</span></span></p>"
        },
        {
          "id": 218610,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selenium</span></span></p>"
        },
        {
          "id": 218611,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc</span></span></p>"
        },
        {
          "id": 218612,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased sexual maturity and hypogonadism in men is seen with deficiency of? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q7447889",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770008,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Zinc</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc is an essential trace mineral that plays a crucial role in various biological functions, including immune response, protein synthesis, wound healing, DNA synthesis, and cell division. It is also vital for normal growth and development during pregnancy, childhood, and adolescence, as well as for proper reproductive function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc Deficiency and Sexual Maturity</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Zinc deficiency in men can lead to delayed sexual maturation and hypogonadism. Hypogonadism refers to reduced function of the gonads (testes in men), which can lead to lower testosterone levels and may result in symptoms such as decreased libido, erectile dysfunction, and reduced secondary sexual characteristics. Zinc is important for the synthesis of testosterone and its deficiency can impair reproductive health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc is essential for male reproductive health, and its deficiency can lead to delayed sexual maturation and hypogonadism.</span></span></span></p>",
      "correct_choice_id": 218611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5962,
      "choices": [
        {
          "id": 23818,
          "text": "<p><span style=\"font-size:18px;\">2 and 4 only</span></p>"
        },
        {
          "id": 23819,
          "text": "<p><span style=\"font-size:18px;\">1 and 2 only</span></p>"
        },
        {
          "id": 23820,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 4</span></p>"
        },
        {
          "id": 23821,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A pregnant woman at 36 weeks gestation is found to have high blood pressure recording and a urine protein of 3+. Concomitant presence of which of the following symptoms would make you suspect imminent eclampsia?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Headache</span></li><li><span style=\"font-size:18px;\">Blurred vision</span></li><li><span style=\"font-size:18px;\">Persistent pedal edema</span></li><li><span style=\"font-size:18px;\">Epigastric pain</span></li></ol>",
      "unique_key": "Q8167294",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Imminent eclampsia is indicated by the presence of severe symptoms in a patient with preeclampsia. The following symptoms are particularly concerning and suggest the risk of progression to eclampsia:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Headache</strong></span></li><li><span style=\"font-size:18px;\"><strong>Blurred vision</strong></span></li><li><span style=\"font-size:18px;\"><strong>Epigastric pain</strong></span></li><li><span style=\"font-size:18px;\"><strong>Vomiting</strong> (though not listed in the options)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. Headache:</strong> Severe, persistent headache is a sign of central nervous system involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. Blurred vision:</strong> Visual disturbances such as blurred vision or seeing spots are due to cerebral or retinal vasospasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>4. Epigastric pain:</strong> Pain in the epigastric or right upper quadrant can indicate hepatic involvement, such as stretching of the Glisson capsule due to liver swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other symptoms not specifically listed:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Vomiting:</strong> This can also be a sign of worsening preeclampsia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. Persistent pedal edema : </strong>While edema can be present in preeclampsia, it is not a specific indicator of imminent eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a pregnant woman with preeclampsia, the presence of headache, blurred vision, and epigastric pain indicates imminent eclampsia and necessitates immediate intervention with prophylactic magnesium sulfate (MgSO4) and planning for delivery to prevent the onset of seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref: Williams text book of obstetrics 26<sup>th</sup> edition Pg 1840, Dutta’s textbook of obstetrics pg 261,262</strong></span></p>",
      "correct_choice_id": 23820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23224,
      "choices": [
        {
          "id": 92860,
          "text": "<p><span style=\"font-size:12pt;\">Uterine prolapse - Vaginal hysterectomy</span></p>"
        },
        {
          "id": 92861,
          "text": "<p><span style=\"font-size:12pt;\">Vault prolapse - Sacrospinous ligament suspension</span></p>"
        },
        {
          "id": 92862,
          "text": "<p><span style=\"font-size:12pt;\">Cystocele - Colposuspension</span></p>"
        },
        {
          "id": 92863,
          "text": "<p><span style=\"font-size:12pt;\">Rectocele - Posterior colporrhaphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following options is incorrectly matched?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q6820595",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769963,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Cystocele - Colposuspension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anterior colporrhaphy is performed for cystocele.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-101304.png\" alt=\"\" width=\"1000\" height=\"420\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cystocele, the appropriate surgical management is anterior colporrhaphy, not colposuspension.</span></p>",
      "correct_choice_id": 92862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54771,
      "choices": [
        {
          "id": 218549,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Misoprostol</span></span></p>"
        },
        {
          "id": 218550,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxytocin</span></span></p>"
        },
        {
          "id": 218551,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ergotamine</span></span></p>"
        },
        {
          "id": 218552,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PGF2 alpha</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which drug is contraindicated in a patient with atonic PPH with a history of hypertension? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q4023762",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769994,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Ergotamine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ergotamine (or methylergometrine) is an ergot alkaloid that is commonly used as a uterotonic agent to manage postpartum hemorrhage (PPH) by promoting uterine contractions. However, it has potent vasoconstrictive properties, which significantly increase vascular resistance and blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with a history of hypertension, the use of ergotamine is contraindicated because its vasoconstrictive effect can lead to a dangerous rise in blood pressure. This increase in afterload can put additional strain on the heart and may precipitate hypertensive crises or other cardiovascular complications. Therefore, ergotamine is avoided in hypertensive patients, particularly in those with chronic hypertension or other cardiovascular diseases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Other Options:</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Misoprostol:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Misoprostol is a prostaglandin E1 analogue that is also used to manage postpartum hemorrhage. It induces uterine contractions but does not have significant vasoconstrictive effects. Therefore, it is not contraindicated in patients with hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Oxytocin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Oxytocin is another uterotonic agent that works by stimulating uterine contractions. While it can cause mild vasodilation, it does not have the strong vasoconstrictive properties of ergotamine and is generally safe to use in hypertensive patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. PGF2 alpha:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Certain prostaglandins can increase blood pressure and should be used with caution, but they are not as strongly contraindicated as ergotamine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ergotamine is contraindicated in patients with hypertension due to its potent vasoconstrictive effects, which can significantly increase blood pressure and cause cardiovascular complications. This drug should be avoided in hypertensive patients, especially when managing postpartum hemorrhage.</span></span></span></p>",
      "correct_choice_id": 218551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23223,
      "choices": [
        {
          "id": 92856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Degranulated neutrophils</span></span></span></p>"
        },
        {
          "id": 92857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelial cells covered by bacteria </span></span></span></p>"
        },
        {
          "id": 92858,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardenella vaginalis with Bacillin rods </span></span></span></p>"
        },
        {
          "id": 92859,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doderlein bacili in the macrophage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman comes in with a grayish-white vaginal discharge. Upon conducting a gram stain of the discharge, clue cells are observed. What are clue cells?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q8435202",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769962,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Epithelial cells covered by bacteria </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells are epithelial cells that are covered by bacteria, which gives them a distinctive appearance. In the context of bacterial vaginosis, these cells appear with a fuzzy or irregular border due to the presence of small gram-negative bacilli adhering to their surface. The presence of clue cells is a hallmark of bacterial vaginosis, a condition caused by an imbalance in the normal vaginal flora.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Degranulated neutrophils</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Degranulated neutrophils are not clue cells. Neutrophils are involved in the immune response, and their degranulation refers to the release of granules that contain enzymes and other substances. They do not have the fuzzy appearance characteristic of clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Gardenella vaginalis with Bacillin rods</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Gardenella vaginalis is a bacterium associated with bacterial vaginosis, but clue cells are not specifically Gardenella vaginalis with Bacillin rods. Clue cells are epithelial cells covered by various types of bacteria, not a specific bacterium or rod-shaped bacteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Doderlein bacilli in the macrophage</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Doderlein bacilli (lactobacilli) are normally present in the vagina and help maintain a healthy environment. They are not found within macrophages, nor are they related to the appearance of clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells are epithelial cells covered by bacteria, and their presence is indicative of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_44.jpg\" style=\"height:374px; width:500px\" /></span></span></span></span></p>",
      "correct_choice_id": 92857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23219,
      "choices": [
        {
          "id": 92840,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV ELISA</span></span></span></p>"
        },
        {
          "id": 92841,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VDRL</span></span></span></p>"
        },
        {
          "id": 92842,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dark ground microscopy</span></span></span></p>"
        },
        {
          "id": 92843,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Culture</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant female visited the obstetrics and gynecology outpatient department (OBG OPD) for her regular prenatal examination. Her past pregnancy involved a stillbirth at 28 weeks. She has a history of engaging in sexual relations with multiple partners and recalls a painless sore on her vulva before her previous pregnancy. What initial investigative step should be taken for this patient?</span></span>&nbsp;(INICET MAY 2023)</p>",
      "unique_key": "Q8060003",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769958,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) VDRL</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given scenario with a pregnant female has a history of stillbirth and painless genital ulcer is suggestive of Syphilis. So, Venereal disease research laboratory test (VDRL test) will be the first investigation to be done.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SYPHILIS IN PREGNANCY</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caused by Treponema pallidum</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary Syphilis &ndash; Characterized by painless, nontender, single papule over the genitalia, that rapidly becomes eroded and usually becomes indurated, and is called a hard chancre.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kassowitz Law &ndash; gradually improving fetal outcomes in congenital syphilis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Screening test &ndash; VDRL (done for all antenatal patients; May be false positive)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">USG: FGR, hepatomegaly, fetal anemia, hydrops, placentomegaly</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment &ndash; Benzathine penicillin 2.4 million U</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. HIV ELISA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: HIV ELISA is done routinely for screening antenatal patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dark ground microscopy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dark ground microscopy is done when an active ulcer is present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Culture</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Treponema pallidum can&rsquo;t be cultured. It is not the preferred method to diagnose or screen syphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a pregnant woman with a history of stillbirth and a painless genital ulcer, the initial investigation should be the VDRL test to screen for syphilis, as syphilis can significantly impact pregnancy outcomes and requires prompt treatment.</span></span></span></p>",
      "correct_choice_id": 92841,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5995,
      "choices": [
        {
          "id": 23950,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-D, 3-C, 4-B</span></span></span></p>"
        },
        {
          "id": 23951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-D, 2-B, 3-C, 4-A</span></span></span></p>"
        },
        {
          "id": 23952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-C, 2-D, 3-B, 4-A</span></span></span></p>"
        },
        {
          "id": 23953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-A, 2-B, 3-D, 4-C</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following disorders causing secondary amenorrhea with their respective lab findings:&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-172314.png\" style=\"height:196px; width:600px\" /></p>",
      "unique_key": "Q5091772",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770025,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-A, 2-D, 3-C, 4-B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary amenorrhea is the absence of menses for more than three months in girls or women who previously had regular menstrual cycles or six months in girls or women who had irregular menses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian failure: FSH and LH levels will be very high, estrogen levels are low</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman&#39;s syndrome: As the cause in the endometrium, hormonal levels are normal.&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS: Alteration in the LH/FSH ratio</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&#39;s syndrome/ pituitary apoplexy: Hypogonadotrophic hypogonadism: So FSH and LH are low and so is Estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To correctly diagnose the underlying cause of secondary amenorrhea, it is essential to understand and interpret the hormonal profiles associated with different conditions:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian Failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Elevated FSH and LH levels with decreased estradiol indicate ovarian insufficiency.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Low levels of FSH, LH, and estradiol suggest an endometrial cause, such as scarring.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS (Polycystic Ovary Syndrome):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically characterized by normal FSH, elevated LH, and normal estradiol levels, reflecting an imbalance in gonadotropins.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Normal levels of FSH, LH, and estradiol are indicative of pituitary insufficiency, where the pituitary gland fails to stimulate the ovaries.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of gynecology 3<sup>rd</sup> edition Pg 380,</span></strong></span></span></p>",
      "correct_choice_id": 23950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5999,
      "choices": [
        {
          "id": 23966,
          "text": "<p><span style=\"font-size:12pt;\">2, 4</span></p>"
        },
        {
          "id": 23967,
          "text": "<p><span style=\"font-size:12pt;\">1, 2</span></p>"
        },
        {
          "id": 23968,
          "text": "<p><span style=\"font-size:12pt;\">1, 3</span></p>"
        },
        {
          "id": 23969,
          "text": "<p><span style=\"font-size:12pt;\">2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following investigations is used to diagnose unicornuate uterus?&nbsp;</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Falloposcopy</span></li><li><span style=\"font-size:12pt;\">Laparoscopy</span></li><li><span style=\"font-size:12pt;\">HSG</span></li><li><span style=\"font-size:12pt;\">X-ray</span></li></ol>",
      "unique_key": "Q8547666",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770029,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Laparoscopy:</strong> This is a minimally invasive surgical procedure that allows direct visualization of the pelvic organs, including the uterus. It is effective in diagnosing structural anomalies like a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. HSG (Hysterosalpingogram):</strong> This is an X-ray procedure where a contrast dye is injected into the uterine cavity and fallopian tubes. It helps in visualizing the shape of the uterine cavity and the patency of the fallopian tubes, making it useful in diagnosing a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 2, 4:</strong> While laparoscopy (2) is correct, X-ray (4) alone is not specific or detailed enough to diagnose a unicornuate uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 1, 2:</strong> Falloposcopy (1) is used to visualize the interior of the fallopian tubes, not to diagnose uterine anomalies. Laparoscopy (2) is correct but falloposcopy is not appropriate for this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 1, 3:</strong> Similar to option B, falloposcopy (1) is not relevant for diagnosing uterine anomalies, even though HSG (3) is correct.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Falloposcopy:</strong> Refers to the visualization of the interior of the fallopian tube lumen and tubal ostia using a flexible fiber optic device via hysteroscope.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis of Mullerian Anomalies:</strong> Can be achieved through various methods, including:</span><ol><li><span style=\"font-size:12pt;\">Ultrasound (Preferably 3D USG)</span></li><li><span style=\"font-size:12pt;\">MRI (Investigation of choice)</span></li><li><span style=\"font-size:12pt;\">HSG</span></li><li><span style=\"font-size:12pt;\">Hystero-laparoscopy</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopy and HSG are effective diagnostic tools for identifying unicornuate uterus and other Mullerian anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 47, William’s textbook of gynecology 3<sup>rd</sup> edition pg418</strong></span></p>",
      "correct_choice_id": 23969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23229,
      "choices": [
        {
          "id": 92880,
          "text": "<p><span style=\"font-size:12pt;\">Diagnostic laparoscopy</span></p>"
        },
        {
          "id": 92881,
          "text": "<p><span style=\"font-size:12pt;\">Laparotomy</span></p>"
        },
        {
          "id": 92882,
          "text": "<p><span style=\"font-size:12pt;\">HSG</span></p>"
        },
        {
          "id": 92883,
          "text": "<p><span style=\"font-size:12pt;\">TVS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman experiences a 2-year history of infertility, as well as experiencing dyspareunia and dysmenorrhea. She has a retroverted uterus and is sensitive in the Douglas pouch. What should be the subsequent course of action in her management?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q9493170",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769968,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) TVS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this case, the initial step in the diagnostic evaluation of suspected endometriosis is transvaginal ultrasound (TVS). TVS is the first-line imaging modality used to assess pelvic structures and identify abnormalities such as endometriomas or nodularity in the pouch of Douglas. While laparoscopy is the gold standard for diagnosing endometriosis and allows for direct visualization and biopsy, it is generally reserved for cases where non-invasive methods are inconclusive or when surgical intervention is planned. TVS provides valuable initial information and helps in guiding further diagnostic and therapeutic steps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Diagnostic laparoscopy</strong>: Although laparoscopy is the definitive diagnostic procedure for endometriosis, it is not typically the first step. TVS is preferred initially to assess the presence of endometriosis-related changes and determine if more invasive procedures are necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Laparotomy</strong>: Laparotomy is a more invasive surgical approach generally reserved for cases requiring larger abdominal incisions or when laparoscopy is not feasible. It is not typically used as an initial diagnostic tool for endometriosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. HSG (Hysterosalpingography)</strong>: HSG is used primarily to evaluate the patency of the fallopian tubes and uterine cavity. While it can assess tubal factor infertility, it does not provide information specific to endometriosis or the pelvic structures affected by it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The first step in the management of suspected endometriosis is to perform transvaginal ultrasound (TVS) to evaluate pelvic structures and identify abnormalities.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-103004.png\" alt=\"\" width=\"1000\" height=\"840\"></p>",
      "correct_choice_id": 92883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54780,
      "choices": [
        {
          "id": 218585,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby O –ve, DCT -ve</span></p>"
        },
        {
          "id": 218586,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby O –ve, DCT +ve</span></p>"
        },
        {
          "id": 218587,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby +ve, DCT +ve</span></p>"
        },
        {
          "id": 218588,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby +ve, DCT -ve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with O negative and husband B positive delivered a baby. Has received anti-D prophylaxis at 28 weeks. In which of the following conditions will you give anti-D post-delivery? (INICET MAY 2024)</span></p>",
      "unique_key": "Q9913988",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770003,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Baby +ve, DCT -ve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases where an Rh-negative mother has delivered a baby, the administration of anti-D immunoglobulin post-delivery is crucial if the baby is Rh-positive and the Direct Coombs Test (DCT) is negative.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Rh incompatibility:</strong> The Rh-negative mother may develop antibodies against Rh-positive fetal red blood cells if fetal-maternal hemorrhage occurs. To prevent this alloimmunization and protect future pregnancies, anti-D immunoglobulin is given to neutralize any fetal Rh-positive red blood cells that might have entered the maternal circulation during delivery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Direct Coombs Test (DCT):</strong> This test checks whether antibodies are already attached to the baby's red blood cells. A negative DCT indicates that the fetal RBCs are free of maternal antibodies. If the DCT is negative and the baby is Rh-positive, anti-D is administered to the mother to prevent the formation of antibodies in her system.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The administration of anti-D within 72 hours of delivery is standard practice to ensure that any fetal red blood cells in the mother’s circulation are neutralized, thereby preventing Rh sensitization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Baby O negative, DCT negative:</strong> In this, anti D is not required as the baby's blood group is Rh negative so there is NO risk of isoimmunization</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Baby O negative, DCT positive:</strong> In this, anti D is not required as the baby's blood group is Rh negative so there is NO risk of iso immunization</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Baby Positive, DCT positive:</strong> In this patient although the Baby is Rh positive , but DCT is positive which means Abs have already formed in the mother and hence there is no use of giving her Anti D</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Administer anti-D immunoglobulin to an Rh-negative mother after delivery if the baby is Rh-positive and the Direct Coombs Test (DCT) is negative to prevent Rh sensitization and protect future pregnancies.</span></p>",
      "correct_choice_id": 218588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6077,
      "choices": [
        {
          "id": 24277,
          "text": "<p><span style=\"font-size:12pt;\">11-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24278,
          "text": "<p><span style=\"font-size:12pt;\">14-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24279,
          "text": "<p><span style=\"font-size:12pt;\">13-year-old girl with Tanner stage 5 breasts</span></p>"
        },
        {
          "id": 24280,
          "text": "<p><span style=\"font-size:12pt;\">12-year-old with Tanner stage 4 breasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following patients would be classified as having primary amenorrhea?</span>&nbsp;(INICET NOV 2022)</p>",
      "unique_key": "Q6263330",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770035,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 14-year-old girl with Tanner stage 1 breasts</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Primary amenorrhea</strong> is defined as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">No menstruation by age 13 in the absence of secondary sexual characteristics.</span></li><li><span style=\"font-size:12pt;\">No menstruation by age 15 in the presence of secondary sexual characteristics.</span></li></ul></li><li><span style=\"font-size:12pt;\">In this context:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Option A</strong>: An 11-year-old girl with Tanner stage 1 breasts would not be classified as having primary amenorrhea since she is not yet 13.</span></li><li><span style=\"font-size:12pt;\"><strong>Option B</strong>: A 14-year-old girl with Tanner stage 1 breasts meets the criteria for primary amenorrhea because she is older than 13 and has no secondary sexual characteristics (Tanner stage 1 breasts).</span></li><li><span style=\"font-size:12pt;\"><strong>Option C</strong>: A 13-year-old girl with Tanner stage 5 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Option D</strong>: A 12-year-old with Tanner stage 4 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 11-year-old girl with Tanner stage 1 breasts</strong>: The girl is too young to be classified as having primary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 13-year-old girl with Tanner stage 5 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 12-year-old with Tanner stage 4 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary amenorrhea is defined as the absence of menstruation by age 13 without secondary sexual characteristics or by age 15 with secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroff’s gynecologic endocrinology 7th edition pg401, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 450</strong></span></p>",
      "correct_choice_id": 24278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54777,
      "choices": [
        {
          "id": 218573,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 12 mg 24 hourly 2 doses</span></span></p>"
        },
        {
          "id": 218574,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></span></p>"
        },
        {
          "id": 218575,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 12 hourly 2 doses</span></span></p>"
        },
        {
          "id": 218576,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 24 hourly 4 doses</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the dose of corticosteroids for lung maturity? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q1790598",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770000,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Dexamethasone 6 mg 12 hourly 4 doses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are administered to pregnant women who are at risk of preterm delivery (before 34 weeks of gestation) to enhance fetal lung maturity and reduce the risk of neonatal respiratory distress syndrome. The correct dosing regimen for corticosteroids is crucial for their effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">and <strong>Betamethasone</strong> are the two corticosteroids commonly used for this purpose:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is given as 6 mg intramuscularly every 12 hours, totaling four doses. This regimen ensures adequate fetal lung maturation by delivering consistent steroid levels over 48 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Betamethasone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is typically administered as 12 mg intramuscularly, given in two doses 24 hours apart. This regimen also effectively promotes fetal lung maturity but involves fewer doses compared to Dexamethasone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In this specific case, the correct answer is <strong>Dexamethasone 6 mg 12 hourly 4 doses</strong> because it follows the standard protocol for promoting lung maturity in fetuses at risk of preterm birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For fetal lung maturity, the standard dosing regimen of Dexamethasone is 6 mg intramuscularly every 12 hours for a total of 4 doses. This regimen is effective in reducing the risk of neonatal respiratory distress syndrome in preterm infants.</span></span></span></p>",
      "correct_choice_id": 218574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6081,
      "choices": [
        {
          "id": 24293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniotic fluid volume</span></span></span></p>"
        },
        {
          "id": 24294,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal tone</span></span></span></p>"
        },
        {
          "id": 24295,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Daily fetal movement count</span></span></span></p>"
        },
        {
          "id": 24296,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-stress test</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of biophysical profile?&nbsp;</span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q5839909",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Daily fetal movement count</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Daily fetal movement count (DFMC) is not a component of the BPP. DFMC, often assessed using Cardiff&rsquo;s count of 10, is a separate method for monitoring fetal movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Biophysical Profile (BPP) is a comprehensive test used in the assessment of fetal wellbeing. It includes five components, which are scored using the Manning score:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniotic fluid volume (AFV)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal movements</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal tone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal breathing movements</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A low Manning score is indicative of fetal hypoxia and may necessitate further clinical intervention.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, the Modified Biophysical Profile (BPP) includes only two components:</span></span></span>\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniotic fluid index (AFI)</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Amniotic fluid volume</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Amniotic fluid volume is a component of the BPP and helps assess the amount of amniotic fluid surrounding the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fetal tone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fetal tone is another component of the BPP, assessing the baby&#39;s muscle tone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Non-stress test</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Non-stress test (NST) is part of the BPP and evaluates the fetal heart rate in response to fetal movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Biophysical Profile (BPP) consists of five components: NST, AFV, fetal movements, fetal tone, and fetal breathing movements. Daily fetal movement count (DFMC) is not part of the BPP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg 342, Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 122</span></strong></span></span></p>",
      "correct_choice_id": 24295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6086,
      "choices": [
        {
          "id": 24313,
          "text": "<p><span style=\"font-size:12pt;\">Human immunodeficiency virus</span></p>"
        },
        {
          "id": 24314,
          "text": "<p><span style=\"font-size:12pt;\">Herpes simplex virus</span></p>"
        },
        {
          "id": 24315,
          "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
        },
        {
          "id": 24316,
          "text": "<p><span style=\"font-size:12pt;\">Parvovirus B19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Non-immune hydrops is seen in all, except?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q3158492",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770140,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Human immunodeficiency virus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Non-immune hydrops fetalis is a condition characterized by an abnormal accumulation of fluid in at least two fetal compartments, such as ascites, pleural effusion, pericardial effusion, or skin edema, not caused by maternal alloimmunization.</span></li><li><span style=\"font-size:12pt;\">Pathogenesis includes decreased colloid oncotic pressure, increased hydrostatic or central venous pressure, and enhanced vascular permeability. These factors can lead to the development of fetal effusions and anasarca (generalized edema).</span></li><li><span style=\"font-size:12pt;\">Infectious causes of non-immune hydrops include parvovirus B19, syphilis, cytomegalovirus, toxoplasmosis, rubella, enterovirus, varicella, herpes simplex, coxsackievirus, listeriosis, leptospirosis, Chagas disease, and Lyme disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Herpes simplex virus</strong>: This virus can cause non-immune hydrops due to fetal infection leading to systemic inflammation and multiorgan failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Syphilis</strong>: A congenital infection with syphilis can cause severe fetal anemia and hydrops fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Parvovirus B19</strong>: This virus is a well-known cause of non-immune hydrops due to its predilection for infecting red blood cell precursors, leading to severe fetal anemia and hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Human immunodeficiency virus (HIV) is not a cause of non-immune hydrops fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Obstetrics 26<sup>th</sup> edition page no 926</strong></span></p>",
      "correct_choice_id": 24313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5982,
      "choices": [
        {
          "id": 23898,
          "text": "<p><span style=\"font-size:12pt;\">Pap smear</span></p>"
        },
        {
          "id": 23899,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Hysteroscopy</span></p>"
        },
        {
          "id": 23900,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Biopsy</span></p>"
        },
        {
          "id": 23901,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Dilatation and curettage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The following set of instruments are used for which procedure?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2021-1.jpg\" alt=\"\" width=\"300\" height=\"236\"></p>",
      "unique_key": "Q4199335",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770014,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pap smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given set of instruments are commonly used for taking a Pap smear. The instruments include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cusco's bivalved self-retaining speculum:</strong> Used to visualize the cervix.</span></li><li><span style=\"font-size:12pt;\"><strong>Koplin's jar:</strong> Used to store the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Slides to prepare the smear:</strong> Used for placing the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Ayer's spatula and endocervical brush:</strong> Used to collect cells from the ectocervix and endocervix, respectively.</span></li><li><span style=\"font-size:12pt;\"><strong>Fixative containing 95% ethanol:</strong> Used to preserve the collected sample on the slides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysteroscopy:</strong> This procedure involves using a hysteroscope to visualize the inside of the uterine cavity, and the instruments shown are not used for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Biopsy:</strong> While some of these instruments might be used in a cervical biopsy, the specific combination shown is typically for a Pap smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation and curettage:</strong> This procedure involves dilating the cervix and scraping the endometrial lining, which requires different instruments than those shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The set of instruments shown, including Cusco's speculum, Koplin's jar, slides, Ayer's spatula, endocervical brush, and fixative, are used for performing a Pap smear to collect and preserve cervical cell samples for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23898,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6071,
      "choices": [
        {
          "id": 24254,
          "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
        },
        {
          "id": 24255,
          "text": "<p><span style=\"font-size:12pt;\">4</span></p>"
        },
        {
          "id": 24256,
          "text": "<p><span style=\"font-size:12pt;\">6</span></p>"
        },
        {
          "id": 24257,
          "text": "<p><span style=\"font-size:12pt;\">10</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">According to new WHO guidelines, what is the minimum number of antenatal visits recommended to have a positive pregnancy outcome?</span><span style=\"font-size:12.0pt;\">&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q6174537",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 8</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The World Health Organization (WHO) updated its guidelines in 2016, recommending a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality. This guideline is structured to ensure comprehensive monitoring and support throughout the pregnancy:</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12pt;\"><strong>1st Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 1: up to 12 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>2nd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 2: at 20 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 3: at 26 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>3rd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 4: at 30 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 5: at 34 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 6: at 36 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 7: at 38 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 8: at 40 weeks</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These visits are designed to monitor the health of the mother and fetus, provide timely interventions, and offer essential health education.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The WHO recommends a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: The 2016 WHO model for positive pregnancy experience, MOHFW guidelines for antenatal care, ACOG guidelines for antenatal care (2017).</strong></span></p>",
      "correct_choice_id": 24254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23228,
      "choices": [
        {
          "id": 92876,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss+ Metformin + induction of ovulation with urinary gonadotrophins</span></span></span></p>"
        },
        {
          "id": 92877,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss + folic acid, Try for spontaneous induction, if failed move to induction of ovulation</span></span></span></p>"
        },
        {
          "id": 92878,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin + finasteride + Induction of ovulation</span></span></span></p>"
        },
        {
          "id": 92879,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss+ Metformin + Induction of ovulation with clomiphene</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old woman, experiencing 6 years of infertility, possesses a BMI of 33 and exhibits facial hair. Further investigations have diagnosed her with polycystic ovary syndrome (PCOS) and observed tubal spillage from both sides. Given her desire to conceive with her husband, what would be the most suitable management plan for her?&nbsp;</span></span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q9086830",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769967,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Weight loss + folic acid, try for spontaneous induction, if failed move to induction of ovulation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Notably, even a modest weight loss (approximately 5% of body weight) can be beneficial for restoring ovulatory cycles in some obese PCOS patients. Therefore, spontaneous induction is attempted as the first option. Additionally, folic acid is routinely administered as a preventive measure before conception to reduce the risk of neural tube defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_47.jpg\" style=\"height:1225px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Weight loss + Metformin + induction of ovulation with urinary gonadotrophins</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While weight loss and Metformin are both appropriate treatments for PCOS, initiating ovulation induction with urinary gonadotrophins might be premature. Typically, less invasive methods such as Clomiphene or Letrozole are tried before using gonadotrophins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metformin + finasteride + Induction of ovulation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option includes Metformin, which is beneficial for insulin resistance in PCOS, and finasteride, which is used for hirsutism but not typically for fertility management. Finasteride is not used to induce ovulation. This plan overlooks the initial approach of weight loss and the potential for spontaneous ovulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Weight loss + Metformin + Induction of ovulation with clomiphene</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is partially correct. While weight loss and Metformin are appropriate, the recommendation to immediately use Clomiphene for induction without trying for spontaneous ovulation is not aligned with the step-wise approach in fertility management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a woman with PCOS and infertility, the initial management should include weight loss and folic acid supplementation, with attempts at spontaneous ovulation before progressing to more invasive induction methods.</span></span></span></p>",
      "correct_choice_id": 92877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5991,
      "choices": [
        {
          "id": 23934,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concealed sex</span></span></span></p>"
        },
        {
          "id": 23935,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True hermaphroditism</span></span></span></p>"
        },
        {
          "id": 23936,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Female pseudohermaphrodite</span></span></span></p>"
        },
        {
          "id": 23937,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphrodite</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old girl presented with amenorrhea. On examination, she had normal genitalia &amp; normal breast development. Her tests reveal a 5 alpha-reductase deficiency. What could be the probable diagnosis?&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q6489656",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770022,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Male pseudohermaphrodite</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical vignette is suggestive of male pseudohermaphroditism.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In pseudohermaphroditism, the sex glands are of one sex while the external genitalia are of the opposite sex.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphroditism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (male intersex) is an association of male gonads with female external genitalia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 5 alpha-reductase deficiency, there is a failure of the testis to descend to the scrotum and ill development of the penis, thereby resulting in the female phenotype.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Concealed sex:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Criminals may conceal their sex to avoid detection by changing dress or by other methods. This is not relevant to the clinical scenario presented.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. True hermaphroditism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In this condition, the glands of both sexes must be present in the same individual. Such cases are very rare. In most cases, the accessory sex gland is atrophic and lacks functional activity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Female pseudohermaphrodite:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The fault is at the level of an enzyme block of 17-hydroxyprogesterone (21 hydroxylase deficiency is the most common cause) leading to defective production of sex steroids. There are features of virilization (clitoromegaly and the fused labioscrotal folds resemble a rudimentary scrotum). The ovaries may descend within the inguinal canal to lie in the labia majora simulating an inguinal testis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphroditism involves male gonads with female external genitalia. In 5 alpha-reductase deficiency, there is a failure of the testis to descend and ill development of the penis, resulting in a female phenotype despite having male internal genitalia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology&nbsp; 6<sup>th</sup> edition pg 443</span></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>",
      "correct_choice_id": 23937,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5989,
      "choices": [
        {
          "id": 23926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10%</span></span></span></p>"
        },
        {
          "id": 23927,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4%</span></span></span></p>"
        },
        {
          "id": 23928,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6%</span></span></span></p>"
        },
        {
          "id": 23929,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8%</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What should be the ideal percentage for normal sperm morphology in a seminal fluid analysis?</span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5058093",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770020,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 4%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphology is the most important factor/marker of semen analysis. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per the strict criteria, &gt;4% normal forms of morphology must be present.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-280.jpg\" style=\"height:307px; width:900px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal percentage for normal sperm morphology in a seminal fluid analysis is &gt;4% according to WHO 2010 criteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of gynecology 3rd edition Pg442, Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg232</span></strong></span></span></p>",
      "correct_choice_id": 23927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6043,
      "choices": [
        {
          "id": 24142,
          "text": "<p><span style=\"font-size:12pt;\">Starts after peak of uterine contraction and ends after uterine contraction ends</span></p>"
        },
        {
          "id": 24143,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿They are smooth and gradual</span></p>"
        },
        {
          "id": 24144,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿At least 10 beats, 2 times in a 20 min period above baseline</span></p>"
        },
        {
          "id": 24145,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Not associated with accelerations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which statement is false regarding late decelerations?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q5076944",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769954,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) At least 10 beats, 2 times in a 20 min period above baseline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Incorrect. Late decelerations are defined by a decrease in fetal heart rate that is typically more than 15 beats per minute below the baseline and is not defined by a specific frequency above baseline. The characteristic depth and timing of the deceleration are more important than the number of beats or frequency above the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Late decelerations in fetal heart rate patterns are important indicators of fetal well-being and uteroplacental function. late decelerations are indicative of uteroplacental insufficiency. Understanding their characteristics is crucial for accurate assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Starts after peak of uterine contraction and ends after uterine contraction ends:</strong> Correct. Late decelerations start after the peak of the uterine contraction and end after the contraction has concluded. This delayed onset and resolution are key features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. They are smooth and gradual:</strong> Correct. Late decelerations are characterized by a smooth and gradual decline in fetal heart rate (FHR).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Not associated with accelerations:</strong> Correct. Late decelerations are not typically associated with accelerations. This differentiates them from other types of decelerations, such as early decelerations, which can be accompanied by accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Late decelerations are characterized by a smooth, gradual decline in fetal heart rate that begins after the peak of a uterine contraction and returns to baseline after the contraction ends, and they are not defined by beats above baseline or associated with accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 693, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23226,
      "choices": [
        {
          "id": 92868,
          "text": "<p><span style=\"font-size:12pt;\">Uterine torsion</span></p>"
        },
        {
          "id": 92869,
          "text": "<p><span style=\"font-size:12pt;\">Infection of fibroid</span></p>"
        },
        {
          "id": 92870,
          "text": "<p><span style=\"font-size:12pt;\">Red degeneration of fibroid</span></p>"
        },
        {
          "id": 92871,
          "text": "<p><span style=\"font-size:12pt;\">Preterm labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 28 weeks of gestation is experiencing symptoms of fever, acute abdominal pain, and a slight increase in white blood cell count. What is the most likely diagnosis?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q7064192",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769965,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Red degeneration of fibroid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>RED DEGENERATION OF FIBROID</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Occurs in a large fibroid mainly during second half of pregnancy and puerperium.</span></li><li><span style=\"font-size:12pt;\">The cause is not known but is probably due to thrombosis and infarction</span></li><li><span style=\"font-size:12pt;\">The typical presentation is severe abdominal pain especially in the 2nd trimester of pregnancy.</span></li><li><span style=\"font-size:12pt;\">Treatment is symptomatic with analgesics and hydration</span></li><li><span style=\"font-size:12pt;\">TLC is raised but the etiology is not infective</span></li><li><span style=\"font-size:12pt;\"><strong>Surgery is NOT done for red degeneration</strong></span></li><li><span style=\"font-size:12pt;\">Can also happen in the puerperium and in women on combined OCPS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Uterine torsion</strong>: Uterine torsion can lead to birth obstruction, abdominal pain, vaginal bleeding, shock, and urinary and intestinal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Infection of fibroid</strong>: Infection of fibroid can cause blood-stained purulent discharge</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Preterm labor</strong>: Preterm labor doesn’t relate with fever, raised TLC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Red degeneration of fibroid, which typically occurs in the second half of pregnancy or puerperium, presents with severe abdominal pain, fever, and a slight increase in white blood cell count. It is caused by thrombosis and infarction of the fibroid, and treatment is symptomatic with analgesics and hydration. Surgery is not performed for red degeneration.</span></p>",
      "correct_choice_id": 92870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5964,
      "choices": [
        {
          "id": 23826,
          "text": "<p><span style=\"font-size:12pt;\">Cervical carcinoma</span></p>"
        },
        {
          "id": 23827,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Uterine inversion</span></p>"
        },
        {
          "id": 23828,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Uterocervical prolapse</span></p>"
        },
        {
          "id": 23829,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fibroid polyp</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the probable diagnosis from the given clinical image?&nbsp;</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_toNKW9y.jpg\" alt=\"\" width=\"300\" height=\"333\"></span></p>",
      "unique_key": "Q9896870",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770010,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Uterocervical prolapse</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical image shows a case of uterocervical prolapse. This condition is common in elderly women due to weak pelvic muscles and hypoestrogenism, leading to a downward displacement of the uterus and cervix into the vaginal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Uterocervical Prolapse:</strong> The uterus and cervix descend into the vaginal canal, often visualized clearly as in the image provided.</span></li><li><span style=\"font-size:12pt;\"><strong>Differential Diagnoses:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Cervical carcinoma:</strong> Typically presents with a growth or ulceration on the cervix, which is not seen in this image.</span></li><li><span style=\"font-size:12pt;\"><strong>Uterine inversion:</strong> Characterized by the uterus turning inside out, where the cervical rim would be high up around the mass, and no opening would be seen on the presenting portion.</span></li><li><span style=\"font-size:12pt;\"><strong>Fibroid polyp:</strong> Would present as a broad mass without an opening seen on the leading portion, and the cervix would remain high up in its anatomical position.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cervical carcinoma:</strong> The image does not show any growth or ulceration, which are typical features of cervical carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Uterine inversion:</strong> In uterine inversion, the cervix would be high up around the mass, and no opening would be seen on the presenting portion, which is not consistent with the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fibroid polyp:</strong> A fibroid polyp would present as a broad mass without an opening seen on the leading portion, and the cervix would remain high up, which is not consistent with the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical image showing clear visualization of the cervix along with the prolapsed uterus indicates uterocervical prolapse, a condition often seen in elderly women due to weakened pelvic muscles and hypoestrogenism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3<sup>rd</sup> edition pg548, Dutta’s textbook of Gynecology 6<sup>th</sup> edition pg 224</strong></span></p>",
      "correct_choice_id": 23828,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6091,
      "choices": [
        {
          "id": 24333,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succenturiate lobe</span></span></span></p>"
        },
        {
          "id": 24334,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Velamentous insertion of the cord</span></span></span></p>"
        },
        {
          "id": 24335,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Both succenturiate lobe and velamentous insertion</span></span></span></p>"
        },
        {
          "id": 24336,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Normal placenta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image depicts:&nbsp;</span></span>(INICET NOV 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2022-1.jpg\" style=\"height:328px; width:300px\" /></p>",
      "unique_key": "Q2440362",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770142,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Both succenturiate lobe and velamentous insertion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succenturiate lobe</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This refers to a placenta with one or more accessory lobes connected to the main part of the placenta by blood vessels. It is characterized by the presence of a smaller, separate lobe in addition to the main placental mass.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Velamentous insertion of the cord</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This occurs when the umbilical cord inserts into the fetal membranes (chorioamnion) rather than directly into the placental mass. The vessels then travel through the membranes to reach the placenta, making them vulnerable to rupture.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows both conditions: a smaller accessory lobe (succenturiate lobe) and the cord inserting into the membranes rather than the placenta (velamentous insertion).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Succenturiate lobe</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is partially correct but does not account for the velamentous insertion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Velamentous insertion of the cord</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is partially correct but does not account for the succenturiate lobe.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Normal placenta</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect as the image shows abnormalities not seen in a normal placenta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A placenta with both a succenturiate lobe and velamentous insertion of the cord is characterized by the presence of a smaller accessory lobe and the umbilical cord inserting into the fetal membranes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg122, 117, Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 251,253</span></strong></span></span></p>",
      "correct_choice_id": 24335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54774,
      "choices": [
        {
          "id": 218561,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadal dysgenesis</span></p>"
        },
        {
          "id": 218562,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        },
        {
          "id": 218563,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 218564,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen insensitivity syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old girl with primary amenorrhea presents to the OPD. She has Tanner stage IV secondary sexual characters. Her karyotype is 46XX. FSH is 5 and LH is 13. What is the likely diagnosis? (INICET MAY 2024)</span></p>",
      "unique_key": "Q6885804",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769997,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mullerian agenesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with primary amenorrhea, Tanner stage IV secondary sexual characteristics, a 46XX karyotype, and normal gonadotropin levels (FSH and LH). The development of secondary sexual characteristics indicates that the hypothalamic-pituitary-ovarian (HPO) axis is functioning properly, which usually suggests normal ovarian function. Mullerian agenesis (also known as Mayer-Rokitansky-Küster-Hauser syndrome) is a condition where the uterus and part of the vaginal canal are absent, but ovarian function and secondary sexual characteristics remain normal. This condition commonly presents with primary amenorrhea in individuals with a 46XX karyotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gonadal dysgenesis</strong>: Gonadal dysgenesis refers to underdeveloped or non-functional gonads, leading to low estrogen levels and subsequent lack of secondary sexual characteristics. In this case, FSH and LH levels would typically be elevated, not normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kallmann syndrome</strong>: Kallmann syndrome is characterized by a lack of secondary sexual development due to low levels of gonadotropins (FSH and LH). This condition usually presents with delayed or absent puberty, unlike the normal Tanner stage IV development seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Androgen insensitivity syndrome (AIS)</strong>: AIS involves individuals with a 46XY karyotype who are phenotypically female due to the body's inability to respond to androgens. This patient has a 46XX karyotype, ruling out AIS as a possible diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mullerian agenesis is a likely diagnosis in a patient with primary amenorrhea, normal secondary sexual development, normal FSH/LH levels, and a 46XX karyotype.</span></p>",
      "correct_choice_id": 218562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5996,
      "choices": [
        {
          "id": 23954,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 5, 6</span></p>"
        },
        {
          "id": 23955,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 23956,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4, 6</span></p>"
        },
        {
          "id": 23957,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following instruments are used in the caesarean section?&nbsp;</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Bard-Parker blade</span></li><li><span style=\"font-size:12pt;\">Doyen's retractor</span></li><li><span style=\"font-size:12pt;\">Cusco's speculum</span></li><li><span style=\"font-size:12pt;\">Allis forceps</span></li><li><span style=\"font-size:12pt;\">Shirodkar's uterine clamp</span></li><li><span style=\"font-size:12pt;\">Green Armytage forceps</span></li></ol>",
      "unique_key": "Q2733850",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770026,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2, 4, 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Instruments used in a cesarean section</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">BP handle</span></li><li><span style=\"font-size:12pt;\">Allis forceps</span></li><li><span style=\"font-size:12pt;\">Artery forceps</span></li><li><span style=\"font-size:12pt;\">Doyen retractor</span></li><li><span style=\"font-size:12pt;\">Green Armitage forceps</span></li><li><span style=\"font-size:12pt;\">Metzenbaum scissors</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the options</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cusco’s speculum has no role in LSCA It is a vaginal self-retaining speculum with two blades</span></li><li><span style=\"font-size:12pt;\">Shirodkar’s uterine clamp is used in gynecological procedures to hold the uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Identify that Bard-Parker blade, Doyen's retractor, Allis forceps, and Green Armytage forceps are essential instruments used in a cesarean section, while Cusco's speculum and Shirodkar's uterine clamp are not used in this procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition Page no 756</strong></span></p>",
      "correct_choice_id": 23956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54778,
      "choices": [
        {
          "id": 218577,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abdominal circumference &lt; 3rd percentile</span></span></p>"
        },
        {
          "id": 218578,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estimated fetal weight &lt; 3rd percentile</span></span></p>"
        },
        {
          "id": 218579,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absent or reversal of diastolic flow in umbilical artery</span></span></p>"
        },
        {
          "id": 218580,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine A PI &lt; 95%</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are criteria of IUGR except? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q1377258",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770001,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Uterine A PI &lt; 95%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrauterine Growth Restriction (IUGR) is a condition where a fetus is smaller than expected for the number of weeks of pregnancy. It can result from various factors, including placental insufficiency, maternal health issues, or genetic conditions. Several criteria are commonly used to diagnose IUGR:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal circumference &lt; 3rd percentile:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a common marker used in the assessment of IUGR. A small abdominal circumference indicates that the fetus might not be growing adequately.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estimated fetal weight &lt; 3rd percentile:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Like abdominal circumference, if the estimated fetal weight is below the 3rd percentile, it is a strong indicator of IUGR.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent or reversal of diastolic flow in the umbilical artery:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a critical finding on Doppler ultrasound that indicates severe placental insufficiency. It is associated with increased risk of adverse perinatal outcomes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, the option &quot;Uterine A PI &lt; 95%&quot; refers to the uterine artery pulsatility index (PI), which is a measure of the resistance in the uterine artery. In cases of IUGR, resistance is typically <strong>high</strong>, leading to a <strong>high PI</strong>, not low. Therefore, a PI &lt; 95% (indicating low resistance) would not be consistent with IUGR. This is why this option is incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Abdominal circumference &lt; 3rd percentile:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a valid criterion used in the assessment of IUGR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Estimated fetal weight &lt; 3rd percentile:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This criterion is also used in the diagnosis of IUGR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Absent or reversal of diastolic flow in the umbilical artery:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a critical sign of severe IUGR and is often associated with poor perinatal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The uterine artery pulsatility index (PI) is typically high in cases of IUGR due to increased resistance. A low PI (&lt; 95%) would not indicate IUGR, making it the incorrect option in this contex</span></span></span></p>",
      "correct_choice_id": 218580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54781,
      "choices": [
        {
          "id": 218589,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma</span></p>"
        },
        {
          "id": 218590,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella</span></p>"
        },
        {
          "id": 218591,
          "text": "<p><span style=\"font-size:12.0pt;\">HSV</span></p>"
        },
        {
          "id": 218592,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with a history of painful genital ulcers 1 year back has a neonate of 1 week who has lesions on face and body with neurological symptoms. What is the likely infection? (INICET MAY 2024)</span></p>",
      "unique_key": "Q2766841",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770004,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) HSV (Herpes Simplex Virus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question presents a scenario where a woman has a history of painful genital ulcers and has given birth to a neonate who now exhibits lesions on the face and body along with neurological symptoms. This clinical picture strongly suggests a neonatal herpes simplex virus (HSV) infection.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Herpes Simplex Virus (HSV)</strong> is known to cause painful genital ulcers in adults. The virus can remain latent in the body and reactivate later. During pregnancy or delivery, HSV can be transmitted to the neonate, particularly during vaginal delivery if there are active lesions or viral shedding. Neonatal HSV infection can present with vesicular lesions on the skin, eyes, and mouth, and it may also involve the central nervous system, leading to neurological symptoms. Neonatal HSV infection is a serious condition that requires prompt antiviral treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Toxoplasma:</strong> Incorrect because it does not cause painful genital ulcers in the mother or the described symptoms in the neonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Varicella:</strong> Incorrect because, although it can cause skin lesions in neonates, it is not linked with a history of painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CMV:</strong> Incorrect because CMV can cause congenital infections with neurological symptoms, but it is not associated with painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A history of painful genital ulcers in the mother, especially when associated with neonatal lesions and neurological symptoms, is highly suggestive of neonatal HSV infection. HSV is a serious condition that requires immediate medical attention to prevent severe outcomes in the neonate.</span></p>",
      "correct_choice_id": 218591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6045,
      "choices": [
        {
          "id": 24150,
          "text": "<p><span style=\"font-size:12pt;\">Placenta weight at term is 470 g</span></p>"
        },
        {
          "id": 24151,
          "text": "<p><span style=\"font-size:12pt;\">Round-oval with 22 cm diameter</span></p>"
        },
        {
          "id": 24152,
          "text": "<p><span style=\"font-size:12pt;\">Extraplacental membranes and 2-vesseled umbilical cord present</span></p>"
        },
        {
          "id": 24153,
          "text": "<p><span style=\"font-size:12pt;\">Central thickness &gt; 2.5 cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are correct regarding normal placenta, except:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q8755889",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769956,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Extraplacental membranes and 2-vesseled umbilical cord present</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12pt;\">The statement in option C is incorrect regarding the normal placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Extraplacental membranes and 2-vesseled umbilical cord present:</strong> In a normal placenta, the umbilical cord typically contains three vessels (two arteries and one vein), not two. The presence of extraplacental membranes (membranes extending beyond the placental margins) is not a feature of a normal placenta; it is rather an abnormal finding if present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Placenta weight at term is 470 g:</strong> This is correct. The average weight of a term placenta is around 500 grams, but it can range from approximately 450 to 700 grams. The option provides a reasonable estimate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Round-oval with 22 cm diameter:</strong> This is partially correct. The normal placenta is indeed round to oval, but the average diameter is about 15-20 cm, not 22 cm. The provided diameter exceeds the typical range.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Central thickness &gt; 2.5 cm:</strong> This is correct. The normal thickness of the placenta at term is greater than 2.5 cm, commonly around 2.5 to 4 cm. A thickness greater than 2.5 cm falls within the normal range.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">The normal placenta at term typically weighs around 500 grams, has a diameter of 15-20 cm, is 2.5 cm thick, and has a 3-vessel umbilical cord with a central insertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 245 Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54784,
      "choices": [
        {
          "id": 218601,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 218602,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 218603,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertical vaginal septum</span></p>"
        },
        {
          "id": 218604,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young girl presents with retention of urine and cyclical abdominal pain. On examination, there is a tense bluish bulge seen at the introitus. The diagnosis is? (INICET MAY 2024)</span></p>",
      "unique_key": "Q4701591",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770006,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Imperforate hymen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An imperforate hymen is a congenital disorder where the hymen, a thin membrane that typically surrounds or partially covers the vaginal opening, completely obstructs the vaginal opening. This condition can lead to the accumulation of menstrual blood within the vagina (hematocolpos) and uterus (hematometra), resulting in cyclical abdominal pain and urinary retention due to pressure on the bladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The classic presentation includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cyclical abdominal pain</strong>: This occurs as menstrual blood accumulates but cannot exit the body, leading to distension and discomfort.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Retention of urine</strong>: The accumulated blood can exert pressure on the bladder and urethra, causing difficulty in urination.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tense bluish bulge at the introitus</strong>: This is a distinctive finding in imperforate hymen, where the accumulated blood stretches the hymen, causing it to appear bluish and bulging at the vaginal opening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment for an imperforate hymen typically involves making a cruciate incision in the hymen to drain the accumulated blood (hematocolpos) and relieve the symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Transverse vaginal septum:</strong> This condition involves a fibrous or muscular wall across the vagina, which can also cause symptoms similar to an imperforate hymen, such as hematocolpos and urinary retention. However, it does not usually present with the characteristic tense bluish bulge at the introitus because the septum is thicker and the blood does not push against the hymen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vertical vaginal septum:</strong> A vertical vaginal septum is a partition that divides the vaginal canal into two parts. While it may lead to reproductive issues or dyspareunia, it typically does not cause urinary retention or cyclical pain as described in this case, nor does it present with a bluish bulge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mullerian agenesis:</strong> This is a congenital absence of the uterus, cervix, and upper part of the vagina. Patients with this condition often present with primary amenorrhea but do not typically have cyclical abdominal pain or urinary retention. Additionally, there would be no bluish bulge at the introitus because there is no accumulation of blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of cyclical abdominal pain, urinary retention, and a tense bluish bulge at the introitus in a young girl strongly suggests an imperforate hymen. Early diagnosis and surgical intervention can prevent complications and relieve symptoms.</span></p>",
      "correct_choice_id": 218601,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6088,
      "choices": [
        {
          "id": 24321,
          "text": "<p><span style=\"font-size:12pt;\">Platinum resistant if recurrence &gt; 12 months</span></p>"
        },
        {
          "id": 24322,
          "text": "<p><span style=\"font-size:12pt;\">Partial platinum resistant if recurrence is within 6-12 months</span></p>"
        },
        {
          "id": 24323,
          "text": "<p><span style=\"font-size:12pt;\">Platinum sensitive if recurrence &gt; 6 months of starting primary therapy</span></p><p>&nbsp;</p>"
        },
        {
          "id": 24324,
          "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the treatment of recurrent ovarian cancer?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q7236054",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770141,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Platinum sensitive if recurrence &gt; 6 months &nbsp;of starting primary therapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Platinum-refractory disease</strong>: This includes women who progress during primary chemotherapy. It has the worst prognosis, as these patients do not respond to platinum-based chemotherapy at all.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-resistant disease</strong>: This includes women who relapse within 6 months of completing primary therapy. Bevacizumab has been approved for the treatment of platinum-resistant disease due to its ability to inhibit angiogenesis, which is crucial for tumor growth and metastasis.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-sensitive disease</strong>: This includes women who relapse more than 6 months after completing primary therapy. These patients are considered to have a better prognosis and are treated with a platinum-based combination such as carboplatin and paclitaxel or gemcitabine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Platinum resistant if recurrence &gt; 12 months</strong>: This statement is incorrect. If the recurrence occurs more than 12 months after treatment, it is considered platinum-sensitive, not resistant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Partial platinum resistant if recurrence is within 6-12 months</strong>: This statement is not a recognized classification. The classification focuses on the 6-month mark to distinguish between resistant and sensitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Platinum-sensitive recurrent ovarian cancer is characterized by a recurrence occurring more than 6 months after completing primary therapy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/al-35.jpg\" alt=\"\" width=\"500\" height=\"275\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Berek and Novak’s gynecology 15<sup>th</sup> edition pg 1387</strong></span></p>",
      "correct_choice_id": 24323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6040,
      "choices": [
        {
          "id": 24130,
          "text": "<p><span style=\"font-size:12pt;\">Factor II</span></p>"
        },
        {
          "id": 24131,
          "text": "<p><span style=\"font-size:12pt;\">Factor VII</span></p>"
        },
        {
          "id": 24132,
          "text": "<p><span style=\"font-size:12pt;\">Factor VIII</span></p>"
        },
        {
          "id": 24133,
          "text": "<p><span style=\"font-size:12pt;\">Factor XI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following coagulation factors increase in pregnancy except:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q8156956",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Factor XI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pregnancy induces a hypercoagulable state to prepare the body for the increased risk of bleeding during delivery. This state is characterized by an increase in several coagulation factors, which enhances clot formation.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Factor II (Prothrombin):</strong> Increases during pregnancy. This contributes to a higher risk of clotting.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor VII:</strong> Increases during pregnancy, aiding in the clotting process.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor VIII:</strong> Also increases during pregnancy, enhancing clotting factors and overall coagulation.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor XI:</strong> Does not increase during pregnancy. In fact, Factor XI levels are slightly decreased in pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Factor II:&nbsp;</strong>Factor II increases during pregnancy, contributing to the hypercoagulable state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Factor VII:&nbsp;</strong>Factor VII levels increase during pregnancy, supporting the increased coagulation needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Factor VIII</strong>: Factor VIII increases during pregnancy, which is consistent with the overall increase in clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Factor XI is the coagulation factor that does not increase during pregnancy and may actually decrease slightly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 508, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5985,
      "choices": [
        {
          "id": 23910,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4, 3</span></p>"
        },
        {
          "id": 23911,
          "text": "<p><span style=\"font-size:12pt;\">2, 1, 3, 4</span></p>"
        },
        {
          "id": 23912,
          "text": "<p><span style=\"font-size:12pt;\">3, 1, 2, 4</span></p>"
        },
        {
          "id": 23913,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Arrange the following in sequential order with regards to the steps of collection of samples for pap smear testing:&nbsp;</span>(INICET NOV 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Use posterior vaginal wall retractor</span></li><li><span style=\"font-size:12pt;\">Take the sample</span></li><li><span style=\"font-size:12pt;\">Make smear on a slide</span></li><li><span style=\"font-size:12pt;\">Fix the smear</span></li></ol>",
      "unique_key": "Q2502049",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770017,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence for the steps of collection of samples for pap smear testing is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Procedure of taking a pap smear:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Use posterior vaginal wall retractor:</strong> The patient is put in a dorsal position, and Cusco's speculum is introduced to visualize the cervix.</span></li><li><span style=\"font-size:12pt;\"><strong>Take the sample:</strong> The ectocervix is scraped with Ayre's spatula, and the endocervix is scraped with a cytobrush.</span></li><li><span style=\"font-size:12pt;\"><strong>Make smear on a slide:</strong> The samples are spread separately on 2 different glass slides.</span></li><li><span style=\"font-size:12pt;\"><strong>Fix the smear:</strong> The slide is immediately fixed using 95% ethyl alcohol (either immersed or sprayed). After immersion in fixative for 30 minutes, the slide is removed and air dried.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Steps:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Staining:</strong> The fixed slide is stained with Papanicolaou stain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence for collecting samples for a pap smear is to first use a posterior vaginal wall retractor to visualize the cervix, take the sample, make the smear on a slide, and then fix the smear using 95% ethyl alcohol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23913,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6044,
      "choices": [
        {
          "id": 24146,
          "text": "<p><span style=\"font-size:12pt;\">Not age specific</span></p>"
        },
        {
          "id": 24147,
          "text": "<p><span style=\"font-size:12pt;\">35-55 years</span></p>"
        },
        {
          "id": 24148,
          "text": "<p><span style=\"font-size:12pt;\">55-85 years</span></p>"
        },
        {
          "id": 24149,
          "text": "<p><span style=\"font-size:12pt;\">Both of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the age group distribution for vulval cancer?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6748919",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769955,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 55-85 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>55-85 years:</strong> Correct. The majority of vulval cancer cases are diagnosed in women aged 55 to 85 years. The average age of diagnosis is between 60 and 65 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Vulval cancer primarily affects older women, and its age distribution is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Not age specific:</strong> Incorrect. Vulval cancer is not \"not age specific\"; it is specifically associated with an older age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. 35-55 years:</strong> Incorrect. Although vulval cancer can occur in younger women, the majority of cases are diagnosed in the older age group, typically between 55 and 85 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Both of the above:</strong> Incorrect. The age distribution for vulval cancer does not cover both age groups mentioned (35-55 years and 55-85 years) equally. The more accurate distribution is predominantly in the 55-85 years range.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Vulval cancer predominantly affects women aged 55 to 85 years, with the average diagnosis occurring between 60 and 65 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 333, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23220,
      "choices": [
        {
          "id": 92844,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal candidiasis</span></p>"
        },
        {
          "id": 92845,
          "text": "<p><span style=\"font-size:12pt;\">Increased normal vaginal discharge</span></p>"
        },
        {
          "id": 92846,
          "text": "<p><span style=\"font-size:12pt;\">Bacterial vaginosis</span></p>"
        },
        {
          "id": 92847,
          "text": "<p><span style=\"font-size:12pt;\">Chlamydia infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman who is using oral contraceptive pills (OCPs) experiences white vaginal discharge without itching or a foul odor. The discharge causes yellow staining on her underwear. Upon examination, the discharge reveals the presence of typical lactobacilli and an acidic pH. What is the most likely diagnosis in this case?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q8162193",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769959,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Increased normal vaginal discharge</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given clinical scenario suggests a diagnosis of Leucorrhea (Increased vaginal discharge).&nbsp;Leucorrhea presents with excessive whitish, yellowish, or greenish vaginal discharge. It is non-irritant, no purulent and non-offensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Vaginal candidiasis</strong>: Vaginal candidiasis presents with itching and a white thick, curdy discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bacterial vaginosis</strong>: Bacterial vaginosis is characterized by a thin, gray, foul-smelling discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Chlamydia infection</strong>: Chlamydia infection can by asymptomatic or present with discharge but is not associated with yellow discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Increased normal vaginal discharge, known as leucorrhea, can occur in women using oral contraceptive pills. This discharge is typically white or yellow, non-irritant, no purulent, no offensive, and associated with the presence of lactobacilli and an acidic pH.</span></p>",
      "correct_choice_id": 92845,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5990,
      "choices": [
        {
          "id": 23930,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luteal phase LH</span></span></span></p>"
        },
        {
          "id": 23931,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post luteal phase LH</span></span></span></p>"
        },
        {
          "id": 23932,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH in the follicular phase</span></span></span></p>"
        },
        {
          "id": 23933,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian hormone (AMH)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the best measures ovarian reserve?&nbsp;</span></span></span>(INICET NOV 2021)</p>",
      "unique_key": "Q7856557",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770021,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Anti-Mullerian hormone (AMH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian Hormone (AMH)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a glycoprotein secreted by the granulosa cells of pre-antral follicles. It is the best marker of ovarian reserve because it can be tested on any day of the cycle.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Values and Interpretation:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal value:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2-6.8 ng/mL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poor ovarian reserve:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &lt;1 ng/mL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic Ovary Disease (PCOD) and Hyperstimulation Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &gt;10 ng/mL</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tests for ovarian reserve:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Measured in the early follicular phase (Day 2 or 3 of the menstrual cycle). High FSH means the ovarian reserve is getting depleted.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum estradiol values:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Measured on day 3 of the cycle. Serum estradiol &gt;75 pg/mL indicates ovarian hypofunction.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antral follicular count on ultrasound:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Counts less than 4-5 on days 2-5 denote poor response to hormones.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibin B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Values &lt;40 pg/mL indicate poor reserve.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Luteal phase LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Not a reliable measure of ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Post luteal phase LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Not a reliable measure of ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. FSH in the follicular phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While useful, it is less reliable than AMH for assessing ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian Hormone (AMH) is the best marker of ovarian reserve as it can be tested on any day of the menstrual cycle and provides a reliable measure of the ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition Pg 528,529, William&rsquo;s textbook of gynecology 3<sup>rd</sup> edition pg435</span></strong></span></span></p>",
      "correct_choice_id": 23933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6041,
      "choices": [
        {
          "id": 24134,
          "text": "<p><span style=\"font-size:12pt;\">Hospitalize, send urine and blood cultures and start on antibiotics.</span></p>"
        },
        {
          "id": 24135,
          "text": "<p><span style=\"font-size:12pt;\">Oral antibiotics once afebrile</span></p>"
        },
        {
          "id": 24136,
          "text": "<p><span style=\"font-size:12pt;\">Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given</span></p>"
        },
        {
          "id": 24137,
          "text": "<p><span style=\"font-size:12pt;\">Discharge if afebrile for 72 h; Continue antibiotics for 5 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant lady at 20 weeks of gestation comes with complaints of acute onset fever, and pain in the right lumbar region. It is associated with chills, nausea, and vomiting. Urinalysis reveals the presence of E. coli and a diagnosis of acute pyelonephritis is made. Which of the following is incorrect regarding the management of acute pyelonephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6934510",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769952,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Discharge if afebrile for 72 h; Continue antibiotics for 5 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of acute pyelonephritis during pregnancy involves several key steps to ensure effective treatment and prevent complications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hospitalization:</strong> Necessary for intravenous antibiotics and monitoring.</span></li><li><span style=\"font-size:12pt;\"><strong>Urine and Blood Cultures:</strong> Essential for identifying the pathogen and tailoring antibiotic therapy.</span></li><li><span style=\"font-size:12pt;\"><strong>Intravenous Crystalloids:</strong> Used to maintain adequate urine output (≥50 mL/h) and ensure proper hydration.</span></li><li><span style=\"font-size:12pt;\"><strong>Antibiotics:</strong> Initially given intravenously, with the switch to oral antibiotics once the patient is afebrile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The incorrect statement is <strong>Option D</strong>. The correct management protocol dictates:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Discharge Criteria:&nbsp;The patient can be discharged once afebrile for 24 hours, not 72 hours.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Duration of Antibiotics:&nbsp;The recommended course of antibiotics is 7 to 10 days, not just 5 days.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hospitalize, send urine and blood cultures and start on antibiotics:</strong> Correct. Hospitalization, urine and blood cultures, and starting antibiotics are all appropriate steps in managing acute pyelonephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Oral antibiotics once afebrile:</strong> Correct. Switching to oral antibiotics is appropriate once the patient is afebrile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given:</strong> Correct. Maintaining a urine output of &gt; 50 mL/h and using intravenous crystalloids are standard practices to manage hydration and ensure adequate renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharge from the hospital should be considered once the patient is afebrile for 24 hours, and antibiotics should be continued for 7 to 10 days in cases of acute pyelonephritis in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2594, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5997,
      "choices": [
        {
          "id": 23958,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vulval hematoma</span></span></span></p>"
        },
        {
          "id": 23959,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Condyloma accuminata</span></span></span></p>"
        },
        {
          "id": 23960,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Vulval cancer</span></span></span></p>"
        },
        {
          "id": 23961,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bartholin cyst</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most likely diagnosis?&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_7PtUv03.jpg\" style=\"height:211px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7615929",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770027,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Vulval cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a 4 cm &times; 5 cm irregular fungating lesion present on the left labium majus of the vulva. The most likely diagnosis is vulvar carcinoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vulvar cancer is typically characterized by irregular, fungating, or ulcerative lesions on the vulva. These lesions can be painful and may bleed or discharge.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vulval hematoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Vulval hematomas may occur due to direct trauma or accidental injuries. They present as a localized collection of blood within the vulvar tissues, leading to swelling and bruising, but they do not typically form irregular fungating lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Condyloma acuminata:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Condyloma acuminata, also known as genital warts, are commonly caused by HPV types 6 and 11.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They appear as multiple, small, cauliflower-like growths and are not typically large, irregular, or fungating.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bartholin cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A Bartholin cyst occurs when the duct of the Bartholin gland gets blocked due to infection, resulting in a buildup of glandular secretions. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It presents as a swelling on one side of the vaginal opening, but it is typically smooth and round, not irregular and fungating.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vulvar cancer often presents as an irregular, fungating lesion on the vulva.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition pg 337,338</span></strong></span></span></p>",
      "correct_choice_id": 23960,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23232,
      "choices": [
        {
          "id": 92892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 alpha reductase deficiency </span></span></span></p>"
        },
        {
          "id": 92893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">17 alpha hydroxylase deficiency </span></span></span></p>"
        },
        {
          "id": 92894,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen insensitivity syndrome </span></span></span></p>"
        },
        {
          "id": 92895,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Swyer syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old girl comes in with primary amenorrhea and indications of virilization. She displays underdeveloped breasts and pubic hair consistent with prepubertal stages, rated at Tanner stage 2. She has a closed-off vaginal canal and noticeable enlargement of the clitoris. Despite her female sex, her testosterone levels are within the male range. Her genetic makeup is 46XY. What is the likely medical diagnosis in this case?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q9146024",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769991,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 5 alpha reductase deficiency </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given scenario points to a diagnosis of 5 alpha reductase deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 alpha reductase deficiency causes inability to convert testosterone to DHT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When DHT levels are low, newborns will possess external genitalia with a feminine appearance. These youngsters are commonly brought up as girls until they reach puberty, at which point they begin to display signs of masculinization due to the influence of testosterone. As a result, clitoromegaly becomes evident. The absence of estrogen conversion from testosterone results in limited breast growth. Scanty pubic hair is observed since its growth is contingent on both testosterone and dihydrotestosterone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_49.jpg\" style=\"height:533px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 17 alpha hydroxylase deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Leads to reduced formation of corticosteroids, sex hormones and increased mineralocorticoids (causing hypokalemia and hypertension). Patient with XY chromosome presents with atypical genitalia and undescended testes. Patient with XX chromosome lacks secondary sexual development.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Androgen insensitivity syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Defect in androgen receptor resulting in female-appearing genetic male (46, XY); female external genitalia with scant axillary and pubic hair, rudimentary vagina; uterus and fallopian tubes absent due to persistence of anti-Mullerian hormone from testes. Patients develop normal functioning testes. Patient has increased testosterone, estrogen &amp; LH as compared to other sex chromosome disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Swyer syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 46 XY gonadal dysgenesis; Absent secondary sexual characters, but normal female internal and external genitalia. Gonadectomy needs to be done.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-alpha reductase deficiency causes primary amenorrhea and virilization in genetic females (46XY), resulting in the inability to convert testosterone to dihydrotestosterone (DHT). This leads to female external genitalia at birth and masculinization at puberty, with signs such as clitoromegaly and underdeveloped breasts.</span></span></span></p>",
      "correct_choice_id": 92892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5981,
      "choices": [
        {
          "id": 23894,
          "text": "<p><span style=\"font-size:12pt;\">Inhibin B</span></p>"
        },
        {
          "id": 23895,
          "text": "<p><span style=\"font-size:12pt;\">Unconjugated Estriol (E3)</span></p>"
        },
        {
          "id": 23896,
          "text": "<p><span style=\"font-size:12pt;\">AFP</span></p>"
        },
        {
          "id": 23897,
          "text": "<p><span style=\"font-size:12pt;\">hCG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the quadruple screening test?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q1234441",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770013,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Inhibin B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The triple and Quadruple test are done between 15 – 21 weeks.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-279.jpg\" alt=\"\" width=\"900\" height=\"274\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">*Easy to remember: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The quadruple screening test includes Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein (AFP), and Inhibin A. Inhibin B is not included in the quadruple test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23894,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23227,
      "choices": [
        {
          "id": 92872,
          "text": "<p><span style=\"font-size:12pt;\">Medroxyprogesterone acetate</span></p>"
        },
        {
          "id": 92873,
          "text": "<p><span style=\"font-size:12pt;\">Cabergoline</span></p>"
        },
        {
          "id": 92874,
          "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
        },
        {
          "id": 92875,
          "text": "<p><span style=\"font-size:12pt;\">Letrozole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug is not given in endometriosis?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q3548218",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769966,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol is avoided in the treatment of endometriosis because it can promote the growth of endometriotic lesions. Estradiol is a form of estrogen, which can stimulate the endometrial tissue and potentially exacerbate the symptoms and progression of endometriosis. The goal in managing endometriosis is to reduce estrogen levels or block estrogen’s effects to help resolve the lesions and alleviate symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Medroxyprogesterone acetate</strong>: This is used in the treatment of endometriosis. Medroxyprogesterone acetate is a type of progesterone that helps create a state of endometrial atrophy, which can reduce the growth of endometriotic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cabergoline</strong>: This drug is typically used to treat hyperprolactinemia but is not a standard treatment for endometriosis. While not commonly used in endometriosis management, its use is not contraindicated as estradiol is.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Letrozole</strong>: This is an aromatase inhibitor that lowers estrogen levels and is used in the treatment of endometriosis. By reducing estrogen levels, letrozole helps decrease the growth of endometriotic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol is avoided in the treatment of endometriosis because it can exacerbate the condition by promoting the growth of endometriotic lesions</span></p>",
      "correct_choice_id": 92874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6039,
      "choices": [
        {
          "id": 24126,
          "text": "<p><span style=\"font-size:12pt;\">1 or 2 doses</span></p>"
        },
        {
          "id": 24127,
          "text": "<p><span style=\"font-size:12pt;\">2 doses</span></p>"
        },
        {
          "id": 24128,
          "text": "<p><span style=\"font-size:12pt;\">1 dose</span></p>"
        },
        {
          "id": 24129,
          "text": "<p><span style=\"font-size:12pt;\">3 doses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Recommended HPV vaccination schedule for 9- to 14-year-olds according to WHO SAGE guidelines is:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3093181",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769950,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1 or 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Recommended Schedule:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>One or Two-Dose Schedule</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>One dose</strong> is considered sufficient for healthy individuals aged 9–14 years.</span></li><li><span style=\"font-size:16px;\">Alternatively, a <strong>two-dose schedule</strong> may be administered, with the second dose given <strong>6–12 months</strong> after the first.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key Considerations:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Primary Target Group</strong>: Girls aged <strong>9–14 years</strong>, ideally before the onset of sexual activity.</span></li><li><span style=\"font-size:16px;\"><strong>Immunocompromised Individuals</strong>: Should receive <strong>at least two doses</strong>, and where feasible, <strong>three doses</strong>, regardless of age.</span></li><li><span style=\"font-size:16px;\"><strong>Vaccination of Boys</strong>: While the primary focus is on girls, vaccinating boys is recommended where feasible and affordable to enhance herd immunity and prevent HPV-related diseases in males.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The WHO SAGE guidelines recommend 1 or 2 doses of HPV vaccine for 9- to 14-year-olds.</span></p>",
      "correct_choice_id": 24126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6084,
      "choices": [
        {
          "id": 24305,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High fetal head station</span></span></span></p>"
        },
        {
          "id": 24306,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparity</span></span></span></p>"
        },
        {
          "id": 24307,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuraxial block</span></span></span></p>"
        },
        {
          "id": 24308,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorioamnionitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are causes of uterine dysfunction, except:&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q8438403",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770139,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Multiparity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparity is not a cause of uterine dysfunction; rather, nulliparity (the condition of a woman who has never given birth) is a recognized cause. Uterine dysfunction, particularly hypotonic uterine dysfunction, is associated with several factors, but multiparity is generally associated with a more efficient labor process due to the body&#39;s previous experience with childbirth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of hypotonic uterine dysfunction:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuraxial analgesia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The use of epidural or spinal anesthesia can interfere with uterine contractions.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorioamnionitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is an infection of the amniotic fluid and membranes, which can lead to inflammation and impaired uterine contractility.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: First-time mothers (nulliparous women) are more likely to experience uterine dysfunction due to the unconditioned nature of the uterine muscles.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other factors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanical disruption of myometrial function by a fibroid or pelvic tumor</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal obesity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine mullerian anomaly</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased maternal age</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malposition and malpresentation of the fetus</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contracted pelvis</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. High fetal head station</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: High fetal head station can be associated with labor dystocia and uterine dysfunction as it may indicate issues with the descent of the baby.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Multiparity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Neuraxial block (e.g., epidural) can interfere with effective uterine contractions, leading to uterine dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Chorioamnionitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chorioamnionitis, an infection, can impair uterine contractions and lead to dysfunctional labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity, not multiparity, is a cause of uterine dysfunction. Causes of hypotonic uterine dysfunction include neuraxial analgesia, chorioamnionitis, nulliparity, and mechanical factors such as fibroids or pelvic tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg459, Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 416</span></strong></span></span></p>",
      "correct_choice_id": 24306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6079,
      "choices": [
        {
          "id": 24285,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cry of baby in the womb</span></span></span></p>"
        },
        {
          "id": 24286,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of vagina</span></span></span></p>"
        },
        {
          "id": 24287,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of uterus</span></span></span></p>"
        },
        {
          "id": 24288,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of both vagina and uterus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is vagitus uterinus?&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q1796532",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770036,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cry of baby in the womb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term used to describe the cry of a baby in the womb. It is a rare phenomenon but can occur if there is a rupture of the amniotic sac with air entry, allowing the baby to make crying sounds while still in utero.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus vaginus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term for the cry of the baby in the vagina, which can be heard during delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> causes vaginitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may affect its layers, leading to conditions such as endometritis (infection of the endometrium), myometritis (infection of the myometrium), and perimetritis (infection of the perimetrium).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Infection of vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the vagina causes vaginitis, which is not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Infection of uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the uterus can lead to endometritis, myometritis, or perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Infection of both vagina and uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of both the vagina and uterus involves conditions such as vaginitis and endometritis/myometritis/perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus refers to the cry of a baby in the womb, which is a rare phenomenon that can occur if there is a rupture of the amniotic sac with air entry.</span></span></span></p>",
      "correct_choice_id": 24285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5984,
      "choices": [
        {
          "id": 23906,
          "text": "<p><span style=\"font-size:12pt;\">Anencephaly</span></p>"
        },
        {
          "id": 23907,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Omphalocele</span></p>"
        },
        {
          "id": 23908,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cystic hygroma</span></p>"
        },
        {
          "id": 23909,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Encephalocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A doctor tells a 31-year-old woman, who is 20 weeks pregnant, that her baby has a developmental defect. She has come to you for a second opinion. The following US finding is seen. Identify the defect?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/picture9.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q9594980",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770016,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anencephaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given ultrasound image shows an open neural tube defect in the calvaria (skull), which is consistent with the diagnosis of anencephaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Anencephaly:</strong> Results from incomplete closure of the neural tube. It can be detected as early as 10 to 11 weeks of gestation.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Ultrasound Signs:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\"><strong>Frog eye sign:</strong> Absence of cranial calvaria with prominent orbits, resembling the face of a frog.</span></li><li><span style=\"font-size:12pt;\"><strong>Shower cap sign:</strong> Absence of the cranium leading to the protrusion of a disorganized mass of brain tissue, resembling a shower cap and giving rise to a characteristic triangular facial appearance.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prevention:</strong> Can be prevented by pre-conceptional folic acid supplementation (5 mg) for at least 3 months.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Omphalocele:&nbsp;</strong>Congenital herniation of abdominal contents through a defect in the abdominal wall covered by a membrane. It is different from gastroschisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cystic hygroma:&nbsp;</strong>Lymphangioma occurring in the head-neck region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Encephalocele:</strong> Protrusion of the brain and membranes through a cranial defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anencephaly is an open neural tube defect characterized by the absence of the cranial calvaria and prominent orbits, detectable by ultrasound as early as 10 to 11 weeks of gestation. It can be prevented with pre-conceptional folic acid supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg 201, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg471</strong></span></p>",
      "correct_choice_id": 23906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5986,
      "choices": [
        {
          "id": 23914,
          "text": "<p><span style=\"font-size:12pt;\">Uterotonics after delivery of placenta</span></p>"
        },
        {
          "id": 23915,
          "text": "<p><span style=\"font-size:12pt;\">Controlled cord traction</span></p>"
        },
        {
          "id": 23916,
          "text": "<p><span style=\"font-size:12pt;\">Uterine massage</span></p>"
        },
        {
          "id": 23917,
          "text": "<p><span style=\"font-size:12pt;\">Early cord clamping</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is NOT a part of AMTSL?</span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q2568148",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770018,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Early cord clamping</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Active Management of 3<sup>rd</sup> Stage of Labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Active Management of the Third Stage of Labor (AMTSL) was described by the WHO in 2007 and involves mainly three basic steps:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Administering a uterotonic:</strong> Oxytocin is the uterotonic of choice for AMTSL (10 IU IM/IV).</span></li><li><span style=\"font-size:12pt;\"><strong>Controlled cord traction:</strong> This is done only if a skilled birth attendant is present.</span></li><li><span style=\"font-size:12pt;\"><strong>Uterine massage:</strong> Sustained uterine massage is not recommended for all women who have received uterotonics; instead, postpartum uterine tone assessment for early identification of uterine atony is done.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>AMTSL prevents atonic postpartum hemorrhage (PPH).</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Delayed cord clamping (performed after 1 to 3 minutes after birth) is recommended for all births while initiating simultaneous essential newborn care. This is not to prevent atonic PPH but was introduced along with AMTSL to ensure it is followed.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>WHO Guidelines:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>In 2012:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Emphasized the main three steps.</span></li><li><span style=\"font-size:12pt;\">Oxytocin is the uterotonic of choice.</span></li><li><span style=\"font-size:12pt;\">Controlled cord traction only with a skilled birth attendant.</span></li><li><span style=\"font-size:12pt;\">Delayed cord clamping recommended.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>In 2018:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Additional uterotonics that can be used include:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Carbetocin (100 mcg IM/IV)</span></li><li><span style=\"font-size:12pt;\">Misoprostol (400 or 600 mcg PO – to be used where a skilled birth attendant isn’t available)</span></li><li><span style=\"font-size:12pt;\">Ergometrine/methylergometrine (200 mcg IV except in hypertensive women)</span></li><li><span style=\"font-size:12pt;\">Oxytocin and ergometrine fixed-dose combination (5 IU/500 µg, IM)</span></li></ul></li><li><span style=\"font-size:12pt;\">Injectable prostaglandins (carboprost or sulprostone) are not recommended for the prevention of PPH.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Uterotonics after delivery of placenta:</strong> This is a key component of AMTSL to prevent atonic PPH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Controlled cord traction:</strong> This is part of the AMTSL process to help deliver the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uterine massage:</strong> This is included in AMTSL, specifically for assessing uterine tone post-delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct components of AMTSL include administering a uterotonic, controlled cord traction, and uterine massage. Early cord clamping is not part of AMTSL; instead, delayed cord clamping is recommended.</span></p><p>&nbsp;</p>",
      "correct_choice_id": 23917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6069,
      "choices": [
        {
          "id": 24246,
          "text": "<p><span style=\"font-size:12pt;\">Progestin injection</span></p>"
        },
        {
          "id": 24247,
          "text": "<p><span style=\"font-size:12pt;\">Progestin implants</span></p>"
        },
        {
          "id": 24248,
          "text": "<p><span style=\"font-size:12pt;\">Female sterilization</span></p>"
        },
        {
          "id": 24249,
          "text": "<p><span style=\"font-size:12pt;\">Levonorgestrel-releasing and copper-containing intrauterine devices</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are long acting reversible methods of contraception, except:&nbsp;(INICET NOV 2022)</span></p>",
      "unique_key": "Q7343540",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770030,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Female sterilization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Long-Acting Reversible Contraceptives (LARC) are those which are administered at a frequency of less than once per month. LARC methods include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Intrauterine devices (IUDs):</strong> Such as CuT 380A with a lifespan of 10 years, and the Levonorgestrel-releasing IUD (LNG IUD) with a lifespan of 5 years.</span></li><li><span style=\"font-size:12pt;\"><strong>Implants:</strong> Implanon, which contains etonorgestrel, has a lifespan of 3 years, and Norplant II, which contains LNG, also has a lifespan of 3 years.</span></li><li><span style=\"font-size:12pt;\"><strong>Injectable contraceptives:</strong> Including Depo-Provera (DMPA) which is administered as 150 mg every 3 months, and Norethisterone enanthate (NET-EN) which is administered as 200 mg every 2 months.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Progestin injection:</strong> This is a form of LARC. Injectable contraceptives like DMPA and NET-EN are given at intervals of 2 to 3 months.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Progestin implants:</strong> These are also considered LARC. Implanon and Norplant II are examples of progestin implants with a duration of action up to 3 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Levonorgestrel-releasing and copper-containing intrauterine devices:</strong> Both types of IUDs are classified as LARC. The CuT 380A lasts for up to 10 years, and the LNG IUD lasts for up to 5 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Long-acting reversible contraceptives (LARC) include intrauterine devices (IUDs), progestin implants, and injectable contraceptives, but do not include permanent methods like female sterilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 107,112, 127, Dutta’s textbook of Gynecology 6<sup>th</sup> edition pg 491-492,479,</strong></span></p>",
      "correct_choice_id": 24248,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6094,
      "choices": [
        {
          "id": 24345,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH</span></span></span></p>"
        },
        {
          "id": 24346,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hCG</span></span></span></p>"
        },
        {
          "id": 24347,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH</span></span></span></p>"
        },
        {
          "id": 24348,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GnRH</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which hormone is secreted by placenta? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9089478",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770143,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) hCG</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Human chorionic gonadotropin (hCG)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the hormone secreted by the placenta. It is a glycoprotein produced by the syncytiotrophoblast cells of the placenta.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hCG can be detected in the maternal serum or urine as early as 8-9 days post-fertilization using radioimmunoassay. In early pregnancy, hCG concentrations in plasma double every 1.4-2 days.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary role of hCG is to maintain the corpus luteum during the beginning of pregnancy, ensuring the continued production of progesterone, which is critical for maintaining the uterine lining and supporting pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. LH</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Luteinizing Hormone is produced by the anterior pituitary gland, not by the placenta. It plays a key role in regulating the menstrual cycle and ovulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. FSH</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Follicle-Stimulating Hormone is also produced by the anterior pituitary gland. It is involved in the development of ovarian follicles and the regulation of the menstrual cycle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GnRH</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Gonadotropin-Releasing Hormone is produced by the hypothalamus, it stimulates the anterior pituitary gland to release FSH and LH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Human chorionic gonadotropin (hCG) is a hormone secreted by the placenta, crucial for maintaining early pregnancy by supporting the corpus luteum and progesterone production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg266, Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 66</span></strong></span></span></p>",
      "correct_choice_id": 24346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54782,
      "choices": [
        {
          "id": 218593,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anomaly scan</span></span></p>"
        },
        {
          "id": 218594,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniocentesis</span></span></p>"
        },
        {
          "id": 218595,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorionic villous sampling</span></span></p>"
        },
        {
          "id": 218596,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NIPT</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presents at 18 weeks with low risk of trisomy on quadruple marker and high risk of NTD. What is the next best step? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q4941181",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Anomaly scan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct answer is <strong>Anomaly scan</strong>. This patient has a low risk of trisomy (such as Down syndrome) but a high risk of neural tube defects (NTD) based on the quadruple marker test. The quadruple marker test includes measurements of beta-hCG, unconjugated estriol, inhibin A, and alpha-fetoprotein (AFP). A high level of AFP is associated with an increased risk of NTDs, such as spina bifida.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given the elevated risk for NTDs, the most appropriate next step is an <strong>anomaly scan</strong>, specifically a targeted imaging for fetal anomaly (TIFA) scan. This ultrasound, typically performed between 18 and 20 weeks of gestation, has a high sensitivity (up to 99%) for detecting structural anomalies, particularly neural tube defects. The scan is a non-invasive way to assess the fetus for physical defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Amniocentesis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While amniocentesis can detect chromosomal abnormalities and some structural defects, it is invasive and carries a small risk of complications. Since the concern here is structural (NTD) rather than chromosomal, and the anomaly scan is highly effective and non-invasive, amniocentesis is not the first choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Chorionic villous sampling (CVS):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CVS is another invasive procedure used for early genetic testing, usually performed in the first trimester. It is not useful at 18 weeks and is not the best test for detecting structural anomalies like NTDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. NIPT (Non-Invasive Prenatal Testing):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> NIPT is a screening tool for chromosomal aneuploidies (like trisomy 21, 18, and 13). Since the patient already has a low risk of trisomy, NIPT is unnecessary and does not address the high risk of NTD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a patient with a high risk of neural tube defects identified by elevated alpha-fetoprotein on a quadruple marker test, the best next step is an anomaly scan (TIFA), which is highly effective in identifying structural fetal abnormalities, including NTDs</span></span></span></p>",
      "correct_choice_id": 218593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6042,
      "choices": [
        {
          "id": 24138,
          "text": "<p><span style=\"font-size:18px;\">4 contractions in 20 min and 8 contractions in 60 min with changes in cervix</span></p>"
        },
        {
          "id": 24139,
          "text": "<p><span style=\"font-size:18px;\">Cervical dilatation &gt; 2 cm</span></p>"
        },
        {
          "id": 24140,
          "text": "<p><span style=\"font-size:18px;\">More than 80 percent effaced cervix</span></p>"
        },
        {
          "id": 24141,
          "text": "<p><span style=\"font-size:18px;\">Cervix posterior in position</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">All of the following are the diagnostic criteria for preterm labor except?</span></p>",
      "unique_key": "Q2472082",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Cervix posterior in position</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Preterm labor (PTL) is labor that occurs before the 37th week of gestation. Accurate diagnosis involves evaluating several key criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Contractions:</strong> At least one regular contraction every 10 minutes, or 4 contractions in 20 minutes, or 8 contractions in 60 minutes, with or without pain.</span></li><li><span style=\"font-size:18px;\"><strong>Cervical Changes:</strong> Cervical dilation greater than 2 cm and more than 80% effacement are significant indicators of preterm labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">The incorrect statement is <strong>Option D</strong>. A cervix that is posterior in position is not a diagnostic criterion for preterm labor. Instead, the cervix's position may be less relevant than its dilation and effacement in the diagnosis of preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. 4 contractions in 20 min and 8 contractions in 60 min with changes in cervix:</strong> Correct. Regular contractions that meet the criteria of 4 in 20 minutes or 8 in 60 minutes, along with changes in the cervix, are used to diagnose preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Cervical dilatation &gt; 2 cm:</strong> Correct. Cervical dilation greater than 2 cm is a diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. More than 80 percent effaced cervix:</strong> Correct. Cervical effacement greater than 80% is another diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The cervix being in a posterior position is not a diagnostic criterion for preterm labor. The diagnosis involves assessing contraction patterns and cervical changes such as dilation and effacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref: Page no 366, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54770,
      "choices": [
        {
          "id": 218545,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abruptio placentae</span></span></p>"
        },
        {
          "id": 218546,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta previa</span></span></p>"
        },
        {
          "id": 218547,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Missed abortion</span></span></p>"
        },
        {
          "id": 218548,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ruptured ectopic pregnancy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman presents with bleeding since 2 days and abdominal pain. Her LMP was 6 weeks back. An ultrasound shows fluid in the pouch of Douglas. What is the diagnosis? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q7188068",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769993,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Ruptured ectopic pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct answer is <strong>Ruptured ectopic pregnancy</strong>. This condition is an emergency where a fertilized egg implants outside the uterus, most commonly in the fallopian tube. As the pregnancy grows, it can cause the tube to rupture, leading to internal bleeding. The classic presentation of a ruptured ectopic pregnancy includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal pain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Due to the rupture and internal bleeding.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vaginal bleeding</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Occurs as a result of the ectopic pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of amenorrhea (missed period)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Indicates an early pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fluid in the pouch of Douglas</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a key diagnostic clue. The pouch of Douglas is the lowest point of the female pelvis, located between the uterus and the rectum. In the case of a ruptured ectopic pregnancy, blood often collects here, visible as fluid on an ultrasound.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Abruptio placentae:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition involves the premature separation of the placenta from the uterus, typically occurring in the third trimester. It is characterized by severe abdominal pain, vaginal bleeding, and a rigid, tender uterus. This scenario does not fit the description of the early pregnancy situation described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Placenta previa:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition occurs when the placenta covers the cervix either partially or completely. It typically presents with painless vaginal bleeding in the second or third trimester, not in the first trimester as described in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Missed abortion:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A missed abortion refers to a situation where the fetus has died but has not been expelled from the uterus. It usually presents with an absence of fetal heart tones on ultrasound and a uterus that is smaller than expected for gestational age. There would not typically be fluid in the pouch of Douglas, which is more indicative of intraperitoneal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In early pregnancy, if a patient presents with abdominal pain, bleeding, and a history of missed periods, with fluid in the pouch of Douglas seen on ultrasound, the most likely diagnosis is a ruptured ectopic pregnancy. This condition requires immediate surgical intervention.</span></span></span></p>",
      "correct_choice_id": 218548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23225,
      "choices": [
        {
          "id": 92864,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases risk of Colon cancer</span></span></span></p>"
        },
        {
          "id": 92865,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of breast cancer</span></span></span></p>"
        },
        {
          "id": 92866,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased risk of endometrial cancer</span></span></span></p>"
        },
        {
          "id": 92867,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases risk of osteoporosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true association related to HRT (Hormone replacement therapy) among the options provided?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q6606855",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769964,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Decreases risk of Colon cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) has been associated with a decreased risk of colon cancer. Studies have shown that estrogen in HRT may have a protective effect against the development of colon cancer. This effect is believed to be related to estrogen&rsquo;s impact on gastrointestinal mucosal growth and repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased risk of breast cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT, particularly with estrogen and progestin, is associated with an increased risk of breast cancer. Long-term use of combined HRT has been shown to elevate the risk of breast cancer in several studies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased risk of endometrial cancer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. Unopposed estrogen (estrogen alone without progestin) increases the risk of endometrial cancer. To mitigate this risk, progestin is often added to HRT in women with an intact uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increases risk of osteoporosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. HRT is actually used prophylactically to reduce the risk of osteoporosis. Estrogen helps maintain bone density and prevent bone loss, which is beneficial in managing osteoporosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone Replacement Therapy (HRT) decreases the risk of colon cancer.</span></span></span></p>",
      "correct_choice_id": 92864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6076,
      "choices": [
        {
          "id": 24273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of knee jerk</span></span></span></p>"
        },
        {
          "id": 24274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotension</span></span></span></p>"
        },
        {
          "id": 24275,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></span></span></p>"
        },
        {
          "id": 24276,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced muscle tone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with eclampsia is started on magnesium sulfate. What is the first sign of magnesium sulfate toxicity?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4909687",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770034,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Loss of knee jerk</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic range</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The therapeutic range of magnesium for the prevention of seizures in eclampsia is 4-7 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of Deep Tendon Reflexes (DTRs)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The first sign of magnesium sulfate toxicity is the loss of DTRs, specifically the knee jerk reflex. This occurs when plasma magnesium levels reach 7-10 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: When plasma magnesium levels reach 10-12 mEq/L, respiratory depression occurs. Beyond 12 mEq/L, respiratory paralysis and respiratory arrest can occur.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac arrest</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cardiac arrest can happen if serum magnesium levels exceed 25 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitoring</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A patient on magnesium sulfate is monitored for toxicity by checking clinical signs, including DTRs, urine output, and respiratory rate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of toxicity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Treatment for magnesium sulfate toxicity involves administering calcium gluconate or calcium chloride (1g intravenously) and discontinuing magnesium sulfate, which usually reverses mild to moderate respiratory depression.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypotension</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypotension is not the first sign of magnesium sulfate toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Respiratory depression occurs at higher magnesium levels (10-12 mEq/L), after the loss of knee jerk reflex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Reduced muscle tone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reduced muscle tone is not the first sign of magnesium sulfate toxicity and is less specific than the loss of DTRs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first sign of magnesium sulfate toxicity is the loss of deep tendon reflexes (knee jerk).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition page 759</span></strong></span></span></p>",
      "correct_choice_id": 24273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5994,
      "choices": [
        {
          "id": 23946,
          "text": "<p><span style=\"font-size:12pt;\">Selective fetal growth restriction</span></p>"
        },
        {
          "id": 23947,
          "text": "<p><span style=\"font-size:12pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 23948,
          "text": "<p><span style=\"font-size:12pt;\">Twin to twin transfusion syndrome</span></p>"
        },
        {
          "id": 23949,
          "text": "<p><span style=\"font-size:12pt;\">Neural tube defects</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following complication is specific to Monochorionic twins?&nbsp;</span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5962018",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770024,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Twin to twin transfusion syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Complications specific to monochorionic twins are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Twin to twin transfusion syndrome (TTTS)</strong>: This is a specific complication seen in monochorionic twins. There is a donor twin and a recipient twin; the donor is anemic and pale with oligohydramnios, while the recipient is polycythemic and may have circulatory overload, ascites, and hydrops. Quintero's staging is used for TTTS, and the treatment involves laser ablation of vessels.</span></li><li><span style=\"font-size:12pt;\"><strong>TRAP sequence (Twin Reversed Arterial Perfusion)</strong>: This is another specific complication seen in monochorionic twins, involving an acardiac twin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Selective fetal growth restriction</strong>: While this can occur in monochorionic twins, it is not specific to them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Polyhydramnios</strong>: This can be seen in various conditions and is not specific to monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Neural tube defects</strong>: These can occur in any pregnancy and are not specific to monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thus, options A, B, and D are not specific complications of monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg904,905</strong></span></p>",
      "correct_choice_id": 23948,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54773,
      "choices": [
        {
          "id": 218557,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Expedite delivery</span></p>"
        },
        {
          "id": 218558,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Wait till 37 weeks</span></p>"
        },
        {
          "id": 218559,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + wait till 37 weeks</span></p>"
        },
        {
          "id": 218560,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + Expedite delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents at 36 weeks with chronic HTN and 3+ proteinuria. Her BP is 170/100 mmHg and she complains of headache and blurring of vision. What is the best management option? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7599765",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769996,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Labetalol + MgSO4 + Expedite delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is presenting with chronic hypertension that has progressed to superimposed preeclampsia, indicated by the development of 3+ proteinuria, a blood pressure of 170/100 mmHg, and symptoms such as headache and blurring of vision. These symptoms and her elevated blood pressure suggest severe preeclampsia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Severe Preeclampsia</strong>: A systolic blood pressure greater than 160 mmHg or a diastolic blood pressure greater than 110 mmHg, along with symptoms like headache and visual disturbances, are indicators of severe preeclampsia. In this case, the patient’s condition requires urgent management to prevent the development of eclampsia, a condition that can lead to seizures and other severe complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management</strong>: The correct management for severe preeclampsia at 36 weeks gestation includes the administration of <strong>Labetalol</strong> to lower the blood pressure, <strong>Magnesium sulfate (MgSO4)</strong> to prevent seizures, and <strong>expedited delivery</strong> to resolve the preeclampsia. After 34 weeks of gestation, delivery is recommended for severe preeclampsia because the risks of continuing the pregnancy outweigh the benefits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Labetalol + MgSO4 + Wait till 37 weeks: </strong>As this is severe preeclampsia, there is a very high risk waiting till 37 weeks. Immediate delivery is indicated after 34 weeks</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Labetalol + Corticosteroids + wait till 37 weeks: </strong>There is no indication for corticosteroids as she has crossed 34 weeks and also there is no indication to wait till 37 weeks as this is severe preeclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Labetalol + Corticosteroids + Expedite delivery:&nbsp;</strong>Although delivery needs to be expedited, there is no indication for corticosteroids as she has crossed 34 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of severe preeclampsia after 34 weeks, immediate delivery, blood pressure control with labetalol, and seizure prophylaxis with magnesium sulfate are essential for optimal maternal and fetal outcomes.</span></p>",
      "correct_choice_id": 218557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5979,
      "choices": [
        {
          "id": 23886,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measure CA 125 levels</span></span></span></p>"
        },
        {
          "id": 23887,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up after 6 weeks</span></span></span></p>"
        },
        {
          "id": 23888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopy</span></span></span></p>"
        },
        {
          "id": 23889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT pelvis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old woman who has had 2 children through normal delivery presents with a dull aching pain over the abdomen, with irregular menses. Per vaginal examination revealed a mass felt through the posterior fornix. A USG showed a clear ovarian cyst of size 5 x 5 cm. What is the next best step?&nbsp;</span></span>(INICET NOV 2021)</p>",
      "unique_key": "Q8279405",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770012,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Follow up after 6 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clear ovarian cyst with minimal symptoms and size less than 8 cm in a woman of reproductive age group is most likely a functional ovarian cyst. The next best step in the management of this case is to follow up after 6-12 weeks and perform a repeat USG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional Ovarian Cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In reproductive-aged women, a clear ovarian cyst less than 8 cm is likely functional.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-Up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The recommended management is to follow up after 6-12 weeks with a repeat ultrasound to check if the cyst resolves on its own.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for Further Intervention:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical treatment is warranted if there are worrying features, the cyst is greater than 8 cm, there are significant symptoms, or CA-125 levels are raised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Measure CA 125 levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CA 125 is a marker for epithelial ovarian tumors and is more relevant in postmenopausal women. It has limited role in premenopausal women with clear, simple cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical intervention such as laparoscopy is not immediately necessary for a 5 cm cyst unless there are concerning features or persistence after follow-up.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. CT pelvis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CT scan is not typically indicated for initial assessment of a simple ovarian cyst detected on ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC Pills:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills have not been proven effective in treating simple ovarian cysts, though they are often used.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Ovarian Cysts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Any simple ovarian cyst less than 5 cm without symptoms can be left alone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a reproductive-aged woman with a clear ovarian cyst less than 8 cm and minimal symptoms, the best approach is to follow up with a repeat ultrasound after 6-12 weeks, rather than immediate intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: RCOG greentop guideline number 62 , Williams textbook of gynecology 3<sup>rd</sup> edition pg217</span></strong></span></span></p>",
      "correct_choice_id": 23887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6030,
      "choices": [
        {
          "id": 24090,
          "text": "<p><span style=\"font-size:12pt;\">Start colloids initially, 4 times the blood lost</span></p>"
        },
        {
          "id": 24091,
          "text": "<p><span style=\"font-size:12pt;\">Primary PPH occurs within 24 hours of childbirth</span></p>"
        },
        {
          "id": 24092,
          "text": "<p><span style=\"font-size:12pt;\">PPH is loss of &gt; 500 ml of blood in vaginal delivery</span></p>"
        },
        {
          "id": 24093,
          "text": "<p><span style=\"font-size:12pt;\">Causes include retained placenta and atony</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements is false regarding post-partum hemorrhage (PPH)?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3282176",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769949,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Start colloids initially, 4 times the blood lost</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The false statement regarding post-partum hemorrhage (PPH) is option A. T<strong>he standard practice for managing PPH is to start intravenous isotonic crystalloids rather than colloids</strong>. Colloids are generally reserved for specific situations and are not the initial choice for fluid resuscitation in PPH. The correct approach involves using crystalloids to replace lost blood volume. The recommendation is not to administer colloids at a volume four times the amount of blood lost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-243.jpg\" alt=\"\" width=\"900\" height=\"387\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Primary PPH occurs within 24 hours of childbirth:</strong> This statement is true. Primary or early postpartum hemorrhage refers to blood loss occurring within the first 24 hours after delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. PPH is loss of &gt; 500 ml of blood in vaginal delivery</strong>: This statement is true. Postpartum hemorrhage is defined as a blood loss greater than 500 ml following a vaginal delivery and more than 1000 ml following a cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Causes include retained placenta and atony</strong>: This statement is true. Common causes of postpartum hemorrhage include uterine atony (failure of the uterus to contract) and retained placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Initial management of post-partum hemorrhage should involve intravenous isotonic crystalloids, not colloids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1894, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23221,
      "choices": [
        {
          "id": 92848,
          "text": "<p><span style=\"font-size:12pt;\">Anovulation</span></p>"
        },
        {
          "id": 92849,
          "text": "<p><span style=\"font-size:12pt;\">Endometriosis</span></p>"
        },
        {
          "id": 92850,
          "text": "<p><span style=\"font-size:12pt;\">Malignancy</span></p>"
        },
        {
          "id": 92851,
          "text": "<p><span style=\"font-size:12pt;\">Bleeding disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of puberty menorrhagia?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q3244151",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769960,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anovulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of puberty menorrhagia. Menorrhagia refers to heavy menstrual bleeding that occurs in a regular cycle. In adolescents, anovulation, which is the failure of the ovary to release an oocyte during a menstrual cycle, frequently leads to heavy or prolonged bleeding due to the lack of a normal hormonal cycle that regulates the endometrial lining. Without the usual cyclical hormonal fluctuations, the endometrial lining may become excessively thick, leading to heavy bleeding when it sheds. This condition is typical in puberty due to the body's ongoing adjustment to hormonal regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Endometriosis</strong>: Endometriosis involves the presence of endometrial tissue outside the uterus, which can cause painful menstruation and potentially contribute to menorrhagia. However, it is less common than anovulation as the primary cause of menorrhagia in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Malignancy</strong>: Malignancy is a rare cause of menorrhagia in puberty. While malignancy can lead to abnormal bleeding, it is not the most common cause in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bleeding disorder</strong>: Bleeding disorders such as von Willebrand disease or hemophilia can cause menorrhagia but are less common compared to anovulation in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of menorrhagia in puberty.</span></p>",
      "correct_choice_id": 92848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6074,
      "choices": [
        {
          "id": 24265,
          "text": "<p><span style=\"font-size:12pt;\">Mifepristone + misoprostol</span></p>"
        },
        {
          "id": 24266,
          "text": "<p><span style=\"font-size:12pt;\">Manual vacuum aspiration</span></p>"
        },
        {
          "id": 24267,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation and evacuation</span></p>"
        },
        {
          "id": 24268,
          "text": "<p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following can be used in first-trimester medical termination of pregnancy (MTP), except:&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q2151200",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770033,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Extra-amniotic instillation of ethacridine lactate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Extra-amniotic instillation of ethacridine lactate</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">This method is typically used for second-trimester abortions. It involves the instillation of ethacridine lactate into the extra-amniotic space to induce abortion. However, it is rarely used nowadays due to advancements in other safer and more effective methods.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Medical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Mifepristone + misoprostol</strong>: A combination of mifepristone (a progesterone receptor antagonist) and misoprostol (a prostaglandin analog) is a common and effective method for first-trimester medical termination of pregnancy.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Surgical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Manual vacuum aspiration</strong>: This is a safe and effective method for terminating a pregnancy in the first trimester.</span></li><li><span style=\"font-size:12pt;\"><strong>Dilatation and curettage</strong>: Another surgical method used to evacuate the contents of the uterus in the first trimester.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mifepristone + misoprostol</strong>: Mifepristone + misoprostol is a commonly used combination for medical termination in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual vacuum aspiration</strong>: Manual vacuum aspiration is a standard procedure for first-trimester abortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Dilatation and evacuation</strong>: Dilatation and evacuation is another method used in the first trimester to terminate a pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate is not used for first-trimester medical termination of pregnancy (MTP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg364,369, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg203</strong></span></p>",
      "correct_choice_id": 24268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5977,
      "choices": [
        {
          "id": 23878,
          "text": "<p><span style=\"font-size:12pt;\">Clomiphene citrate</span></p>"
        },
        {
          "id": 23879,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        },
        {
          "id": 23880,
          "text": "<p><span style=\"font-size:12pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 23881,
          "text": "<p><span style=\"font-size:12pt;\">OCP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not used to treat PCOD?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q1648191",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770011,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Tamoxifen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is not commonly used in the treatment of Polycystic Ovary Disease (PCOD). Tamoxifen is a selective estrogen receptor modulator (SERM) primarily used in the treatment and prevention of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Medical Management of PCOD:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>OCP (Option D):</strong> Oral contraceptive pills regulate the menstrual cycle and hormones and are given to women who are not desirous of fertility to regularize their cycles.</span></li><li><span style=\"font-size:12pt;\"><strong>Metformin (Option B):</strong> Metformin is an insulin sensitizer, which decreases hyperinsulinemia and improves fertility in patients with PCOD.</span></li><li><span style=\"font-size:12pt;\"><strong>Ovulation Induction Drugs:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\"><strong>Clomiphene (Option A):</strong> Clomiphene citrate is commonly used to induce ovulation in women with infertility due to PCOD.</span></li><li><span style=\"font-size:12pt;\"><strong>Letrozole:</strong> Letrozole, an aromatase inhibitor, is the drug of choice for ovulation induction in PCOD.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clomiphene citrate:</strong> Clomiphene is an ovulation induction agent used in the treatment of infertility in women with PCOD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Metformin:</strong> Metformin is used to decrease insulin resistance and hyperinsulinemia in PCOD, which can help in regulating menstrual cycles and improving fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. OCP:</strong> Oral contraceptive pills are used to regulate menstrual cycles and manage hormonal imbalances in women with PCOD who do not seek to become pregnant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is not typically used in the treatment of PCOD. Instead, treatments include oral contraceptive pills, metformin, and ovulation induction agents such as clomiphene and letrozole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3rd edition. Pg 398 Dutta’s textbook of Gynecology 6<sup>th</sup> edition pg470</strong></span></p>",
      "correct_choice_id": 23880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54772,
      "choices": [
        {
          "id": 218553,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrone</span></span></p>"
        },
        {
          "id": 218554,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estradiol</span></span></p>"
        },
        {
          "id": 218555,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estriol</span></span></p>"
        },
        {
          "id": 218556,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugated equine estrogen</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most potent natural estrogen is? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q5996201",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769995,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Estradiol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogens play a crucial role in the development and regulation of the female reproductive system and secondary sexual characteristics. Among the natural estrogens, estradiol is the most potent. Estradiol is primarily produced by the ovaries and is the predominant estrogen during the reproductive years of a woman. It has the highest affinity for estrogen receptors, making it the most effective at eliciting estrogenic responses in the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrone, on the other hand, is the main estrogen found in postmenopausal women and is less potent than estradiol. Estriol is the weakest of the three natural estrogens and is predominantly produced during pregnancy. Conjugated equine estrogen is a mixture of estrogens derived from the urine of pregnant mares and is less potent than estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, estradiol is considered the most potent natural estrogen due to its strong affinity for estrogen receptors and its significant role in reproductive physiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Estrone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although it is a natural estrogen, estrone is less potent than estradiol. It is primarily found in postmenopausal women and does not exert the same level of estrogenic activity as estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Estriol:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This estrogen is the least potent of the natural estrogens and is mainly produced during pregnancy. It has a much lower affinity for estrogen receptors compared to estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Conjugated equine estrogen:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a semi-synthetic mixture of estrogens obtained from horses. While it is used in hormone replacement therapy, its potency is lower than that of estradiol and it is not considered a single natural estrogen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estradiol is the most potent natural estrogen, especially during a woman&rsquo;s reproductive years, due to its high receptor affinity and significant physiological effects</span></span></span></p>",
      "correct_choice_id": 218554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6072,
      "choices": [
        {
          "id": 24258,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester USG is the best assessment</span></span></span></p>"
        },
        {
          "id": 24259,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculated from the last day of the last menstrual period</span></span></span></p>"
        },
        {
          "id": 24260,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></span></span></p>"
        },
        {
          "id": 24261,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crown-rump length is the best measure of period of gestation in the first trimester</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the wrong statement regarding the period of gestation calculation:</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4768891",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770032,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Calculated from the last day of the last menstrual period</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age or period of gestation (POG) refers to the duration of pregnancy calculated from the first day of last menstrual period </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal duration of pregnancy: 280 days (40 weeks)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: <strong>Naegele&rsquo;s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day) </span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add 9 months + 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subtract 3 months and add 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dating the pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester CRL: most accurate (till 14 weeks)</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BPD in the 2nd trimester</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1st trimester USG is the best assessment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because the 1st trimester USG provides the most accurate dating method.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because calculating gestational age in IVF pregnancies relies on the day of embryo transfer or fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Crown-rump length is the best measure of period of gestation in the first trimester</strong>: Correct, because CRL is the best measure for assessing the period of gestation in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age is calculated from the first day of the last menstrual period (LMP), not the last day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg, Dutta&rsquo;s 108, 109, textbook of obstetrics 8<sup>th</sup> edition pg127</span></strong></span></span></p>",
      "correct_choice_id": 24259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54779,
      "choices": [
        {
          "id": 218581,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cabergoline</span></span></p>"
        },
        {
          "id": 218582,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></p>"
        },
        {
          "id": 218583,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ergot alkaloids</span></span></p>"
        },
        {
          "id": 218584,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Misoprostol</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following delivery of a preterm baby, the baby died in the NICU despite all efforts. What medication would be given to the mother for reducing breast tenderness? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q1395830",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770002,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Cabergoline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a dopamine agonist and is the drug of choice for suppressing lactation. It works by inhibiting prolactin secretion from the pituitary gland, which reduces milk production and alleviates breast engorgement and tenderness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline is preferred because it is effective, has a favorable side effect profile, and is well-tolerated by most patients. It is also used in conditions like galactorrhea where suppression of lactation is desired.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Dopamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While dopamine agonists like cabergoline work to suppress prolactin, dopamine itself is not used directly for this purpose in clinical settings. Cabergoline, being a dopamine agonist, is more specifically tailored for this function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Ergot alkaloids</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ergot alkaloids have some dopamine agonist activity and can suppress prolactin, but they are not the drug of choice for lactation suppression due to their side effects and less favorable risk profile compared to cabergoline.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Misoprostol</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Misoprostol is a prostaglandin analog used to prevent gastric ulcers, induce labor, and manage postpartum hemorrhage, but it has no role in lactation suppression or reducing breast tenderness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cabergoline is the preferred medication for suppressing lactation and reducing breast tenderness in cases where breastfeeding is not desired or possible, such as after neonatal death</span></span></span></p>",
      "correct_choice_id": 218581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54776,
      "choices": [
        {
          "id": 218569,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCMA (Monochorionic Monoamniotic)</span></span></p>"
        },
        {
          "id": 218570,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCDA (Monochorionic Diamniotic)</span></span></p>"
        },
        {
          "id": 218571,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MADC (Monoamniotic Dichorionic)</span></span></p>"
        },
        {
          "id": 218572,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DADC (Dichorionic Diamniotic)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which will you not see in twin pregnancy? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q5352974",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769999,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) MADC (Monoamniotic Dichorionic)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct answer is <strong>MADC (Monoamniotic Dichorionic)</strong>. The classification of twin pregnancies is based on the timing of the zygote&#39;s division and the resulting structures, such as the number of chorions (placentas) and amnions (amniotic sacs) that form.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dichorionic Diamniotic (DCDA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins occur when the division happens very early (within the first 72 hours after fertilization), resulting in two separate chorions and amnions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monochorionic Diamniotic (MCDA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins occur when the division happens between the 4th and 8th day after fertilization, after the chorion has formed but before the amniotic sac has split.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monochorionic Monoamniotic (MCMA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> twins result from division that occurs between the 9th and 12th day after fertilization, after both the chorion and amnion have formed, leading to two embryos sharing a single amniotic sac and a single chorion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoamniotic Dichorionic (MADC)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not a possible scenario. The formation of a single amnion with two separate chorions (placentas) does not occur because the chorion forms before the amnion. Thus, this combination is anatomically and developmentally impossible.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. MCMA (Monochorionic Monoamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a recognized type of twin pregnancy where twins share both the chorion and the amnion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. MCDA (Monochorionic Diamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Another recognized type, where twins share a chorion but have separate amniotic sacs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DADC (Dichorionic Diamniotic):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the most common type of twin pregnancy, especially in dizygotic (fraternal) twins, where each twin has its own chorion and amnion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoamniotic Dichorionic (MADC) is not a possible configuration in twin pregnancies. The formation of the amnion and chorion follows a specific sequence that does not allow for this combination. Understanding the timing and resulting structures of zygote division is crucial in determining the type of twin pregnancy.</span></span></span></p>",
      "correct_choice_id": 218571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5983,
      "choices": [
        {
          "id": 23902,
          "text": "<p><span style=\"font-size:12pt;\">Formalin</span></p>"
        },
        {
          "id": 23903,
          "text": "<p><span style=\"font-size:12pt;\">Air dried</span></p>"
        },
        {
          "id": 23904,
          "text": "<p><span style=\"font-size:12pt;\">Normal saline</span></p>"
        },
        {
          "id": 23905,
          "text": "<p><span style=\"font-size:12pt;\">95% ethanol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the fixative used for a pap smear?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q6641651",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770015,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 95% ethanol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common fixative used in a Pap smear is 95% ethyl alcohol (ethanol). This fixative helps preserve the cells collected on the slides for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Formalin:</strong> Formalin (10%) is commonly used as a fixative for histology specimens but is not used for Pap smears.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Air dried:</strong> Air drying is not a method used for preserving Pap smear specimens as it can lead to poor preservation of cellular details.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal saline:</strong> Normal saline is not a fixative. Tissues must be immediately transferred to formol saline if using normal saline temporarily.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The fixative used for a Pap smear is typically 95% ethanol, which helps preserve the cellular details on the slides for accurate cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23905,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23233,
      "choices": [
        {
          "id": 92896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABO incompatibility </span></span></span></p>"
        },
        {
          "id": 92897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 </span></span></span></p>"
        },
        {
          "id": 92898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosomal defect </span></span></span></p>"
        },
        {
          "id": 92899,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha thalassemia major</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the subsequent factors can lead to non-immune hydrops except for:&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q5087126",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769992,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) ABO incompatibility </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-immune hydrops refers to fetal hydrops that occur due to causes other than those related to maternal-fetal blood group incompatibility. ABO incompatibility is an immune-related cause of hydrops, known as immune hydrops, where the mother&#39;s immune system attacks the fetus&#39;s red blood cells due to incompatible ABO blood types. Non-immune hydrops arises from various other causes such as cardiovascular issues, genetic disorders, congenital infections, hematologic disorders, placental problems, and miscellaneous conditions. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Parvovirus B19</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a viral infection that can cause non-immune hydrops by affecting the fetus&#39;s red blood cells, leading to severe anemia and hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chromosomal defect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chromosomal abnormalities, such as trisomy 21, 18, or 13, can cause non-immune hydrops through associated congenital abnormalities or malformations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alpha thalassemia major</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a hematologic disorder that results in severe anemia, which can lead to non-immune hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABO incompatibility leads to immune hydrops and is not a cause of non-immune hydrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-105104.png\" style=\"height:990px; width:1000px\" /></p>",
      "correct_choice_id": 92896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6046,
      "choices": [
        {
          "id": 24154,
          "text": "<p><span style=\"font-size:12pt;\">4-3-2-1</span></p>"
        },
        {
          "id": 24155,
          "text": "<p><span style=\"font-size:12pt;\">4-2-3-1</span></p>"
        },
        {
          "id": 24156,
          "text": "<p><span style=\"font-size:12pt;\">4-3-1-2</span></p>"
        },
        {
          "id": 24157,
          "text": "<p><span style=\"font-size:12pt;\">4-1-2-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Arrange the following steps of dilation and curettage in sequence?&nbsp;</span>(INICET MAY 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Serial dilation</span></li><li><span style=\"font-size:12pt;\">Curettage</span></li><li><span style=\"font-size:12pt;\">Uterine sound</span></li><li><span style=\"font-size:12pt;\">Assessment of uterine size and direction</span></li></ol>",
      "unique_key": "Q8279433",
      "question_audio": null,
      "question_video": null,
      "map_id": 32769957,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 4-3-1-2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence for performing a dilation and curettage (D&amp;C) is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Assessment of uterine size and direction :</strong> Before any procedure, the first step is to assess the size and direction of the uterus to plan the approach and ensure that any interventions are appropriately targeted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Uterine sound :</strong> The next step involves using a uterine sound to measure the depth and assess the shape and orientation of the uterine cavity. This helps to guide the subsequent dilation process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Serial dilation :</strong> After assessing the uterus, serial dilation of the cervix is performed using progressively larger dilators to allow access to the uterine cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Curettage :</strong> Finally, curettage is performed to remove the contents of the uterine cavity, which completes the D&amp;C procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence for dilation and curettage (D&amp;C) is to first assess the uterus, perform uterine sounding, then serial dilation, and finally proceed with curettage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 585, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6080,
      "choices": [
        {
          "id": 24289,
          "text": "<p><span style=\"font-size:12pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 24290,
          "text": "<p><span style=\"font-size:12pt;\">Clear cell adenocarcinoma</span></p>"
        },
        {
          "id": 24291,
          "text": "<p><span style=\"font-size:12pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 24292,
          "text": "<p><span style=\"font-size:12pt;\">Sarcoma botryoides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The daughter of a woman who received diethylstilbestrol during her pregnancy is at higher risk for?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9258403",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770037,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Clear cell adenocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diethylstilbestrol (DES)</strong> is a synthetic estrogen that was previously prescribed to pregnant women to prevent miscarriages and other pregnancy complications. It was later discovered to be a teratogen and is no longer used.</span></li><li><span style=\"font-size:12pt;\">Exposure to DES in utero is known to cause the following conditions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>In girls</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">T-shaped uterus</span></li><li><span style=\"font-size:12pt;\">Cockscomb cervix</span></li><li><span style=\"font-size:12pt;\">Vaginal and cervical clear cell adenocarcinoma</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>In boys</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Micropenis</span></li><li><span style=\"font-size:12pt;\">Hypospadias</span></li><li><span style=\"font-size:12pt;\">Undescended testes</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma is the most common type of cervical cancer. It arises from the ectocervix, at the squamocolumnar junction. This type of cancer is not specifically associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adenocarcinoma</strong>: Adenocarcinoma arises from the endocervix and is not specifically linked to DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sarcoma botryoides</strong>: Sarcoma botryoides is a type of rhabdomyosarcoma that arises from the cervix. It presents as a pinkish polypoidal growth filling up the vagina completely and causes blood-tinged watery discharge. It is not associated with DES exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">DES exposure in utero is specifically associated with an increased risk of clear cell adenocarcinoma of the vagina and cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg42</strong></span></p>",
      "correct_choice_id": 24290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}